<SEC-DOCUMENT>0000950170-24-048287.txt : 20240425
<SEC-HEADER>0000950170-24-048287.hdr.sgml : 20240425
<ACCEPTANCE-DATETIME>20240425160513
ACCESSION NUMBER:		0000950170-24-048287
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240613
FILED AS OF DATE:		20240425
DATE AS OF CHANGE:		20240425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neumora Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001885522
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				844367680
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41802
		FILM NUMBER:		24876176

	BUSINESS ADDRESS:	
		STREET 1:		490 ARSENAL WAY, SUITE 200
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		(857) 760-0900

	MAIL ADDRESS:	
		STREET 1:		490 ARSENAL WAY, SUITE 200
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RBNC Therapeutics, Inc.
		DATE OF NAME CHANGE:	20210929
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>nmra_-_2024_proxy_-_def1.htm
<DESCRIPTION>DEF 14A
<TEXT>
<html>
 <head>
  <title>DEF 14A</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="section-group" style="margin:auto;padding-left:1in;width:6.5in;padding-right:1in;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="border-top:0.5pt solid;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">Washington, D.C. 20549</font></p><p style="border-top:0.5pt solid;padding-top:1pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SCHEDULE 14A</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">Proxy Statement Pursuant to Section 14(a) of the<br>Securities Exchange Act of 1934</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">(Amendment No.    )</font></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;border-bottom:0.5pt solid;text-align:center;"><font style="white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Filed by the Registrant &#9746;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Filed by a party other than the Registrant &#9744;</font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	Preliminary Proxy Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9746;	Definitive Proxy Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	Definitive Additional Materials</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	Soliciting Material under &#167;240.14a-12</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">NEUMORA THERAPEUTICS, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Name of Registrant as Specified In Its Charter)</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment of Filing Fee (Check the appropriate box):</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9746;	No fee required.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	Fee paid previously with preliminary materials.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><img src="img218924107_0.jpg" alt="img218924107_0.jpg" style="width:298px;height:66px;">&#160;</p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">2024<br>Notice &amp; Proxy Statement</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NEUMORA THERAPEUTICS, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">490 Arsenal Way, Suite 200</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Watertown, MA</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TO BE HELD ON JUNE 13, 2024 (AT 8:30 A.M. EASTERN TIME)</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the Stockholders of Neumora Therapeutics, Inc.:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE IS HEREBY GIVEN</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that the Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d;) of Neumora Therapeutics, Inc., a Delaware corporation (the &#x201c;Company&#x201d;), will be held virtually on Thursday, June 13, 2024, at 8:30 a.m. Eastern Time. You will be able to attend and participate in the Annual Meeting online by registering at www.virtualshareholdermeeting.com/NMRA2024 no later than June 12, 2024, at 11:59 p.m. Eastern Time. Once registered you will receive further instructions via email on how to listen to the meeting live, submit questions, and vote. The Annual Meeting will be held for the following purposes:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="text-indent:36pt;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.769%;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To elect two Class I directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected; </font></div></div><div style="text-indent:36pt;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.769%;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To ratify the appointment, by the Audit Committee of the Company&#x2019;s Board of Directors, of Ernst &amp; Young LLP, as the independent registered public accounting firm and independent auditor of the Company for its year ending December 31, 2024; and </font></div></div><div style="text-indent:36pt;font-size:0;margin-top:10pt;justify-content:flex-start;margin-bottom:0;min-width:0.5in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:2.769%;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Only stockholders who owned common stock of the Company at the close of business on April 15, 2024 (the &#x201c;Record Date&#x201d;) can vote at this meeting or any adjournments that take place.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board of Directors recommends that you vote </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the election of the director nominees named in Proposal No. 1 of the Proxy Statement; and </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the ratification of the appointment of Ernst &amp; Young LLP, as the independent registered public accounting firm and independent auditor, as described in Proposal No. 2 of the Proxy Statement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">YOUR VOTE IS IMPORTANT. WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING ONLINE, WE ENCOURAGE YOU TO READ THE ACCOMPANYING PROXY STATEMENT AND OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2023, AND SUBMIT YOUR PROXY AS SOON AS POSSIBLE USING ANY ONE OF THE CONVENIENT VOTING METHODS DESCRIBED IN THE &#x201c;INFORMATION ABOUT THE PROXY PROCESS AND VOTING&#x201d; SECTION IN THE PROXY STATEMENT. IF YOU RECEIVE MORE THAN ONE SET OF PROXY MATERIALS OR NOTICE OF INTERNET AVAILABILITY BECAUSE YOUR SHARES ARE REGISTERED IN DIFFERENT NAMES OR ADDRESSES, EACH PROXY SHOULD BE SIGNED AND SUBMITTED TO ENSURE THAT ALL OF YOUR SHARES WILL BE VOTED.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By Order of the Board of Directors</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ HENRY O. GOSEBRUCH</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Watertown, Massachusetts</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">April 25, 2024</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TABLE OF CONTENTS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:91%;"></td>
     <td style="width:9%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Page</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proxy_statement"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#information_about_proxy"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">INFORMATION ABOUT THE PROXY PROCESS AND VOTING</font><font style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposal_no_1"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSAL NO. 1  ELECTION OF DIRECTORS</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#proposal_no_2"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">PROPOSAL NO. 2  RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND INDEPENDENT AUDITOR</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_the_audit_committee"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</font><font style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#corporate_governance"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">CORPORATE GOVERNANCE</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#transactions_with_related_persons"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">TRANSACTIONS WITH RELATED PERSONS</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#director_compensation"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">DIRECTOR COMPENSATION</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#executive_officers"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">EXECUTIVE OFFICERS</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#executive_compensation"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">EXECUTIVE COMPENSATION</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#security_ownership_certain_beneficial"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#additional_information"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">ADDITIONAL INFORMATION</font></a></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NEUMORA THERAPEUTICS, INC.<br>490 Arsenal Way, Suite 200<br>Watertown, MA</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proxy_statement"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PRO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">XY STATEMENT</font></p><div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:5.231%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">JUNE 13, 2024 (AT 8:30 A.M. EASTERN TIME)</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have sent you this Proxy Statement and the enclosed Proxy Card because the Board of Directors (the &#x201c;Board&#x201d;) of Neumora Therapeutics, Inc. (referred to herein as the &#x201c;Company&#x201d;, &#x201c;Neumora&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d; or &#x201c;our&#x201d;) is soliciting your proxy to vote at our 2024 Annual Meeting of Stockholders (the &#x201c;Annual Meeting&#x201d;) to be held on Thursday, June 13, 2024, at 8:30 a.m. Eastern Time. The Annual Meeting will be held entirely online. You will be able to attend and participate in the Annual Meeting online by registering at www.virtualshareholdermeeting.com/NMRA2024 no later than June 12, 2024, at 11:59 p.m. Eastern Time. Once registered you will receive further instructions via email on how to listen to the meeting live, submit questions, and vote.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This Proxy Statement summarizes information about the proposals to be considered at the Annual Meeting and other information you may find useful in determining how to vote. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Proxy Card is the means by which you actually authorize another person to vote your shares in accordance with your instructions. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to solicitations by mail, our directors, officers and regular employees, without additional compensation, may solicit proxies by telephone, e-mail and personal interviews. We may retain outside consultants to solicit proxies on our behalf as well. All costs of solicitation of proxies will be borne by us. Brokers, custodians and fiduciaries will be requested to forward proxy soliciting material to the owners of stock held in their names, and we will reimburse them for their reasonable out-of-pocket expenses incurred in connection with the distribution of proxy materials.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the rules adopted by the Securities and Exchange Commission (the &#x201c;SEC&#x201d;), we have elected to provide access to our Annual Meeting materials, which include this Proxy Statement and our Annual Report on Form 10-K for the year ended December 31, 2023 (the &#x201c;Form 10-K&#x201d;), over the internet in lieu of mailing printed copies. We will begin mailing the Notice of Internet Availability to our stockholders of record as of April 15, 2024 (the &#x201c;Record Date&#x201d;) for the first time on or about April 25, 2024. The Notice of Internet Availability will contain instructions on how to access and review the Annual Meeting materials and will also contain instructions on how to request a printed copy of the Annual Meeting materials. In addition, we have provided brokers, dealers, banks, voting trustees and their nominees, at our expense, with additional copies of our proxy materials and the Form 10-K so that our record holders can supply these materials to the beneficial owners of shares of our common stock as of the Record Date. The Form 10-K is also available in the &#x201c;Investor Relations&#x2014;SEC Filings&#x201d; section of our website at https://ir.neumoratx.com/.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The only outstanding voting securities of Neumora are shares of common stock, $0.0001 par value per share (the &#x201c;common stock&#x201d;), of which there were 159,452,584 shares outstanding as of the Record Date (excluding any treasury shares). The holders of a majority in voting power of the shares of common stock issued and outstanding and entitled to vote, present in person or represented by proxy, are required to hold the Annual Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="information_about_proxy"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INFORMA</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TION ABOUT THE PROXY PROCESS AND VOTING</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS<br>FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 13, 2024</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, are available on our website at www.neumoratx.com and at www.virtualshareholdermeeting.com/NMRA2024.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unless the context requires otherwise, in this proxy statement the terms &#x201c;Neumora,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our&#x201d; and &#x201c;the Company&#x201d; refer to Neumora Therapeutics, Inc.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QUESTIONS AND ANSWERS REGARDING THE PROXY MATERIALS AND THE VOTING PROCESS</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Why am I receiving these materials?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have made this Proxy Statement and Proxy Card available to you on the internet or, upon your request, have delivered printed proxy materials to you, because the Board is soliciting your proxy to vote at the Annual Meeting, including at any adjournments or postponements of the Annual Meeting. You are invited to attend the Annual Meeting online to vote on the proposals described in this Proxy Statement. However, you do not need to attend the Annual Meeting online to vote your shares. Instead, you may simply complete, sign and return the Proxy Card, or follow the instructions below to submit your proxy over the telephone or on the internet.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">This Proxy Statement, the Notice of Internet Availability, the Notice of Annual Meeting and accompanying Proxy Card will be first made available for access on or about April 25, 2024, to all stockholders of record entitled to vote at the Annual Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Who can vote at the Annual Meeting?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Only stockholders of record at the close of business on the Record Date will be entitled to vote at the Annual Meeting. At the close of business on the Record Date, there were 159,452,584 shares of common stock issued and outstanding and entitled to vote.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stockholder of Record: Shares Registered in Your Name</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If, on the Record Date, your shares were registered directly in your name with the transfer agent for our common stock, Computershare Trust Company, LLC, then you are a stockholder of record. As a stockholder of record, you may vote at the Annual Meeting by attending the Annual Meeting online and following the instructions posted at www.virtualshareholdermeeting.com/NMRA2024, or you may vote by proxy. Whether or not you plan to attend the Annual Meeting online, we encourage you to fill out and return the Proxy Card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If, on the Record Date, your shares were held in an account at a brokerage firm, bank, dealer, custodian or other similar organization acting as nominee, then you are the beneficial owner of shares held in &#x201c;street name&#x201d; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to register to attend the Annual Meeting online at www.virtualshareholdermeeting.com/NMRA2024. You must register online no later than June 12, 2024, at 11:59 p.m. Eastern Time. However, since you are not the stockholder of record, you may not vote your shares at the Annual Meeting by attending the Annual Meeting online unless you request and obtain a valid Proxy Card from your broker or other agent.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What am I being asked to vote on?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You are being asked to vote on two proposals:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proposal 1&#x2014;the election of two Class I directors to hold office until our 2027 annual meeting of stockholders; and </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proposal 2&#x2014;the ratification of the appointment, by the Audit Committee of our Board, of Ernst &amp; Young LLP, as our independent registered public accounting firm and independent auditor for the year ending December 31, 2024.</font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, you are entitled to vote on any other matters that are properly brought before the Annual Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How do I vote?</font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For Proposal 1, you may either vote &#x201c;For&#x201d; the nominees to the Board or you may &#x201c;Withhold&#x201d; your vote for the nominees. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For Proposal 2, you may either vote &#x201c;For&#x201d; or &#x201c;Against&#x201d; or abstain from voting. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Please note that by casting your vote by proxy you are authorizing the individuals listed on the Proxy Card to vote your shares in accordance with your instructions and in their discretion with respect to any other matter that properly comes before the Annual Meeting or any adjournments or postponements thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The procedures for voting are as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stockholder of Record: Shares Registered in Your Name</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a stockholder of record, you may vote at the Annual Meeting online. Alternatively, you may vote by proxy by using the accompanying Proxy Card, over the internet or by telephone. Whether or not you plan to attend the Annual Meeting online, we encourage you to vote by proxy to ensure your vote is counted. Even if you have submitted a proxy before the Annual Meeting, you may still attend the Annual Meeting online and vote online. In such case, your previously submitted proxy will be disregarded.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To vote at the Annual Meeting, you must pre-register to attend the Annual Meeting online and follow the instructions posted at www.virtualshareholdermeeting.com/NMRA2024. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To vote using the Proxy Card, simply complete, sign and date the accompanying Proxy Card and return it promptly in the envelope provided. If you return your signed Proxy Card to us before the Annual Meeting, we will vote your shares in accordance with the Proxy Card. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To vote by proxy over the internet, follow the instructions provided on the Notice of Internet Availability. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To vote by telephone, you may vote by proxy by calling the toll-free number found on the Notice of Internet Availability. </font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Beneficial Owner: Shares Registered in the Name of Broker</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you are a beneficial owner of shares registered in the name of your broker, you should have received a voting instruction card and voting instructions with these proxy materials from that organization rather than from us. Simply complete and mail the voting instruction card to ensure that your vote is counted. To vote at the Annual Meeting online, you must obtain a valid proxy from your broker. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker to request a proxy form.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Who counts the votes?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Broadridge Financial Solutions, Inc. (&#x201c;Broadridge&#x201d;) has been engaged as our independent agent to tabulate stockholder votes. If you are a stockholder of record, your executed Proxy Card is returned directly to Broadridge for tabulation. As noted above, if you hold your shares through a broker, your broker returns one Proxy Card to Broadridge on behalf of all its clients.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How are votes counted?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Votes will be counted by the Inspector of Election appointed for the Annual Meeting, who will separately count &#x201c;For&#x201d; votes for all proposals, and, with respect to Proposal 2, &#x201c;Against&#x201d; votes, abstentions and broker non-votes. In addition, with respect to Proposal 1, the election of directors, the Inspector of Election will count the number of &#x201c;Withheld&#x201d; votes and broker non-votes received. If your shares are held by your broker as your nominee (that is, in &#x201c;street name&#x201d;), you will need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker to vote your shares. If you do not give instructions to your broker, your broker can vote your shares with respect to &#x201c;routine&#x201d; items, but not with respect to</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;non-routine&#x201d; items. See below for more information regarding: &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What are &#x201c;broker non-votes&#x201d;?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Which ballot measures are considered &#x201c;routine&#x201d; or &#x201c;non-routine&#x201d;?</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What are &#x201c;broker non-votes&#x201d;?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Broker non-votes occur when a beneficial owner of shares held in &#x201c;street name&#x201d; does not give instructions to the broker the shares as to how to vote on matters deemed &#x201c;non-routine.&#x201d; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker holding the shares. If the beneficial owner does not provide voting instructions, the broker can still vote the shares with respect to matters that are considered to be &#x201c;routine,&#x201d; but not with respect to &#x201c;non-routine&#x201d; matters. In the event that a broker or other record holder of common stock indicates on a proxy that it does not have discretionary authority to vote certain shares on a particular proposal, then those shares will be treated as broker non-votes with respect to that proposal. Accordingly, if you own shares through a nominee, such as a broker, please be sure to instruct your nominee how to vote to ensure that your vote is counted on each of the proposals.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Which ballot measures are considered &#x201c;routine&#x201d; or &#x201c;non-routine?&#x201d;</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The ratification of the appointment of Ernst &amp; Young LLP, as our independent registered public accounting firm and independent auditor for the year ending December 31, 2024 (Proposal 2) is considered routine under applicable rules. A broker may generally vote on routine matters, and therefore no broker non-votes are expected to exist in connection with Proposal 2. The election of directors (Proposal 1) is considered non-routine under applicable rules. A broker cannot vote without instructions on non-routine matters, and therefore there may be broker non-votes on Proposal 1.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How many votes are needed to approve the proposal?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With respect to Proposal 1, the election of directors, the nominees receiving the highest number of &#x201c;For&#x201d; votes will be elected.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With respect to Proposal 2, the affirmative vote of the majority of votes cast affirmatively or negatively (excluding abstentions and broker non-votes) is required for approval. This is a routine proposal and therefore we do not expect any broker non-votes.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How many votes do I have?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On each matter to be voted upon, you have one vote for each share of common stock you own as of the Record Date.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What if I return a Proxy Card but do not make specific choices?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we receive a signed and dated Proxy Card and the Proxy Card does not specify how your shares are to be voted, your shares will be voted as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;For&#x201d; the election of two nominees for director; and </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;For&#x201d; the ratification of the appointment of Ernst &amp; Young LLP, as our independent registered public accounting firm and independent auditor for the year ending December 31, 2024. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If any other matter is properly presented at the Annual Meeting, your proxy (one of the individuals named on your Proxy Card) will vote your shares in his or her discretion.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Who is paying for this proxy solicitation?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We will pay for the entire cost of soliciting proxies. In addition to these mailed proxy materials, our directors, officers and employees may also solicit proxies in person, by telephone or by other means of communication. Directors, officers and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What does it mean if I receive more than one set of materials?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you receive more than one set of materials, your shares are registered in more than one name or are registered in different accounts. In order to vote all the shares you own, you must either sign and return all of the Proxy Cards or follow the instructions for any alternative voting procedure on each of the Proxy Cards.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Can I change my vote after submitting my proxy?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of three ways:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may submit another properly completed proxy with a later date. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may send a written notice that you are revoking your proxy to the Secretary of the Company at 490 Arsenal Way, Suite 200, Watertown, Massachusetts 02472. </font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may attend the Annual Meeting online and vote by following the instructions at www.virtualshareholdermeeting.com/NMRA2024. Simply attending the Annual Meeting online will not, by itself, revoke your proxy. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If your shares are held by your broker, you should follow the instructions provided by them.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How do I attend the virtual Annual Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The live audio webcast of the Annual Meeting will begin promptly at 8:30 a.m. Eastern Time on June 13, 2024. Online access to the audio webcast will open approximately 15 minutes prior to the start of the Annual Meeting to allow time for our stockholders to log in and test their devices&#x2019; audio system. We encourage you to access the meeting in advance of the designated start time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To attend the Annual Meeting, stockholders will need to log-in to www.virtualshareholdermeeting.com/NMRA2024 using the 16-digit control number on the Proxy Card or voting instruction form.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Can I submit questions prior to or at the virtual Annual Meeting?</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">An online portal will be available to our stockholders at www.virtualshareholdermeeting.com/NMRA2024. Stockholders may access this portal to submit questions and vote 15 minutes prior to, or during, the Annual Meeting. To demonstrate proof of stock ownership, you will need to enter the 16-digit control number received with your Proxy Card or voting instruction form to submit questions and vote at our Annual Meeting. We intend to answer questions submitted before or during the meeting that are pertinent to the Company and the items being brought before stockholder vote at the Annual Meeting, as time permits, and in accordance with the Rules of Conduct for the Annual Meeting. Questions and answers will be grouped by topic and substantially similar questions will be answered only once.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Is technical assistance provided before and during the virtual Annual Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Beginning 15 minutes prior to the start of and during the virtual Annual Meeting, we will have a support team ready to assist stockholders with any technical difficulties they may have accessing or hearing the virtual meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be posted on the virtual stockholder meeting log in page.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">When are stockholder proposals due for next year&#x2019;s Annual Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To be considered for inclusion in next year&#x2019;s proxy materials, your proposal must be submitted in writing by March 15, 2025, to the Secretary of the Company at 490 Arsenal Way, Suite 200, Watertown, Massachusetts 02472; provided, that if the date of the annual meeting is more than 30 days from June 13, 2025, the deadline is a</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reasonable time before we begin to print and send our proxy materials for next year&#x2019;s annual meeting. Pursuant to the Company&#x2019;s bylaws, in order for a stockholder to present a proposal for next year&#x2019;s annual meeting, other than proposals to be included in the proxy statement as described above, or to nominate a director, you must do so between February 13, 2025 and March 15, 2025; provided that if the date of that annual meeting is more than 30 days before or more than 60 days after June 13, 2025, you must give notice not later than the 90th day prior to the 2025 annual meeting date or, if later, the 10th day following the day on which public disclosure of the annual meeting date is first made. You are also advised to review our bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations. In addition to satisfying the foregoing requirements under our bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than no later than 60 calendar days prior to the anniversary of the previous year&#x2019;s annual meeting (i.e. no later than April 14, 2025 for the 2025 Annual Meeting of Stockholders).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">What is the quorum requirement?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if the holders of a majority in voting power of the shares of common stock issued and outstanding and entitled to vote are present in attendance online or represented by proxy at the Annual Meeting. On the Record Date, there were 159,452,584 shares outstanding and entitled to vote. Accordingly, 79,726,293 shares must be represented by stockholders present at the Annual Meeting online or by proxy to have a quorum.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Your shares will be counted toward the quorum only if you submit a valid proxy or vote at the Annual Meeting online. Abstentions and broker non-votes will be counted toward the quorum requirement. If there is no quorum, either the chair of the Annual Meeting or a majority in voting power of the stockholders entitled to vote at the Annual Meeting, in attendance online or represented by proxy, may adjourn the Annual Meeting to another time or place.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">How can I find out the results of the voting at the Annual Meeting?</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Voting results will be announced by the filing of a Current Report on Form 8-K within four business days after the Annual Meeting. If final voting results are unavailable at that time, we will file an amended Current Report on Form 8-K within four business days of the day the final results are available.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Implications of being an &#x201c;emerging growth company.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d; as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have elected to comply with certain reduced public company reporting requirements. These reduced reporting requirements include reduced disclosure about our executive compensation arrangements and no non-binding advisory votes on executive compensation.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We will remain an emerging growth company until the earlier of: (a) the last day of the fiscal year following the fifth anniversary of the consummation of our initial public offering, (b) the last day of the fiscal year in which we have total annual gross revenue of at least $1.235 billion, (c) the last day of the fiscal year in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of the second fiscal quarter of such year, or (d) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposal_no_1"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROP</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OSAL NO. 1</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ELECTION OF DIRECTORS</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board is divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a staggered, three-year term. Unless the Board determines that vacancies (including vacancies created by increases in the number of directors) shall be filled by the stockholders, and except as otherwise provided by law, vacancies on the Board may be filled only by the affirmative vote of a majority of the remaining directors. A director elected by the Board to fill a vacancy (including a vacancy created by an increase in the number of directors) shall serve for the remainder of the full term of the class of directors in which the vacancy occurred and until such director&#x2019;s successor is elected and qualified.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Board currently consists of seven seated directors, divided into the three following classes:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Class I directors: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Kristina Burow and Henry O. Gosebruch, whose current terms will expire at the Annual Meeting; </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Class II directors:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Alaa Halawa and Maykin Ho, Ph.D., whose current terms will expire at the annual meeting of stockholders to be held in 2025; and </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Class III directors: </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul L. Berns, Matthew Fust and David Piacquad whose current terms will expire at the annual meeting of stockholders to be held in 2026. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At each annual meeting of stockholders, the successors to directors whose terms will then expire will be elected to serve from the time of election and qualification until the third subsequent annual meeting of stockholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ms. Burow and Mr. Gosebruch have been nominated to serve as Class I directors and have elected to stand for reelection. If elected, each of Ms. Burow and Mr. Gosebruch will hold office from the date of his election by the stockholders until the third subsequent annual meeting of stockholders in 2027 or until their successor is elected and has been qualified, or until their earlier death, resignation or removal.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the two nominees named below. In the event that any nominee should be unavailable for election as a result of an unexpected occurrence, such shares will be voted for the election of such substitute nominee as the Board may propose. Ms. Burow and Mr. Gosebruch have agreed to serve if elected, and management has no reason to believe that either Ms. Burow or Mr. Gosebruch will be unable to serve. Directors are elected by a plurality of the votes cast at the meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">FOR</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> THE ELECTION OF THE NAMED NOMINEES</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth, for the Class I nominees who are currently standing for re-election, and for our other current directors who will continue in office after the Annual Meeting, information with respect to their ages as of April 15, 2024, and position/office held within the Company:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:55%;"></td>
     <td style="width:1%;"></td>
     <td style="width:5%;"></td>
     <td style="width:1%;"></td>
     <td style="width:26.22%;"></td>
     <td style="width:1.34%;"></td>
     <td style="width:9.44%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Age</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Position/Office Held<br>With the Company</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Director<br>Since</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="text-indent:12.65pt;vertical-align:top;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Class I Directors whose terms expire at the Annual Meeting of Stockholders</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President, Chief Executive Officer and Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Kristina Burow</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)(2)(3)</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2020</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Class II Directors whose terms expire at the 2025 Annual Meeting of Stockholders</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alaa Halawa</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)(3)</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2022</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Maykin Ho, Ph.D.</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)(3)</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">71</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2021</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Class III Directors whose terms expire at the 2026 Annual Meeting of Stockholders</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Executive Chairman</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2020</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Matthew Fust</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)(2)</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">59</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2020</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">David Piacquad</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(3)</font></p></td>
     <td style="text-indent:12.65pt;vertical-align:top;text-align:right;"><p style="text-indent:-12.65pt;padding-left:12.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;border-bottom:0.5pt solid;margin-right:5.5in;text-align:justify;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Member of the Audit Committee. </font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Member of the Compensation Committee. </font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Member of the Nominating and Corporate Governance Committee. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Set forth below is biographical information for the nominees and each person whose term of office as a director will continue after the Annual Meeting. The following includes certain information regarding our directors&#x2019; individual experience, qualifications, attributes and skills that led the Board to conclude that they should serve as directors.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nominees for Election to a Three-Year Term Expiring at the 2027 Annual Meeting of Stockholders</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Kristina Burow</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as a member of our Board since January 2020. Ms. Burow has served as Managing Director of ARCH Venture Partners, a venture capital firm focused on early-stage technology companies, since November 2011 and previously held various roles at ARCH from 2002 to 2011. Ms. Burow is a co-founder of Orbital Therapeutics, a private biotechnology company, and has served on its board of directors since April 2022. She currently serves on the boards of directors of various private biotechnology companies, including Autobahn Therapeutics since February 2018, as well as Mirador Therapeutics, Metsera, and NICO Therapeutics, and various public biotechnology companies, including Boundless Bio since February 2018, Beam Therapeutics since June 2017 and Scholar Rock since 2014. She previously was a co-founder and member of the board of directors of Receptos, a public biotechnology company, acquired by Celgene, and a co-founder and member of the board of directors of Sapphire Energy, a private energy company. Ms. Burow previously served on the board of directors of various public biotechnology and biopharmaceutical companies, including Gossamer Bio, Inc. from 2018 to August 2023, UNITY Biotechnology, Inc. from 2013 to March 2022, Metacrine, Inc. from May 2015 to February 2022, Sienna Biopharmaceuticals, Inc. from 2015 to December 2019, and Vir Biotechnology from January 2017 to September 2020, and various private biotechnology and biopharmaceutical companies, including Vividion Therapeutics, Inc. from January 2017 to October 2021, AgBiome, LLC from 2012 to October 2021, BlackThorn Therapeutics, Inc. (&#x201c;BlackThorn&#x201d;) from 2013 to September 2020 and Lycera Corp. from 2009 to 2020. Prior to joining ARCH, Ms. Burow was an Associate with the Novartis BioVenture Fund and an early employee at the Genomics Institute of the Novartis Research Foundation, both part of Novartis, a public pharmaceutical company. Ms. Burow holds a B.S. in Chemistry from the University of California, Berkeley, an M.A. in Chemistry from Columbia University and an M.B.A. from the University of Chicago Booth School of Business. We believe Ms. Burow is qualified to serve on our Board because of her extensive experience investing in biopharmaceutical and biotechnology companies and her experience on boards of directors in the medical industry.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Henry O. Gosebruch</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has served as our President, Chief Executive Officer and a member of our Board since July 2023. Mr. Gosebruch has also served as a Venture Partner at ARCH Venture Partners, a venture capital firm focused on early stage-technology companies, since June 2023. From December 2015 to February 2023, Mr. Gosebruch served as Executive Vice President and Chief Strategy Officer at AbbVie, a public pharmaceutical company, where he was responsible for AbbVie&#x2019;s corporate strategy, business development, acquisitions, search and evaluation, alliance management, portfolio analytics and strategic venture capital investments. Prior to that, Mr. Gosebruch worked at the North American M&amp;A Group of J.P. Morgan, a public financial services company, from July 1995 to December 2015, most recently serving as its co-head. Mr. Gosebruch has served on the board of directors of Acelyrin, a public biopharmaceutical company, since March 2023. Mr. Gosebruch previously served on the board of directors of Aptinyx, a formerly public biopharmaceutical company, from May 2019 to May 2023. Mr. Gosebruch holds a B.S.E. in Finance from the Wharton School at the University of Pennsylvania, where he currently serves on the advisory board of the Life Sciences &amp; Management Program. We believe Mr. Gosebruch is qualified to serve on our Board because of his extensive experience in the biopharmaceutical sector, mergers and acquisitions, business development and corporate strategy and long-range planning.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Directors Continuing in Office Until the 2025 Annual Meeting of Stockholders</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Maykin Ho, Ph.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as a member of our Board since April 2021. Dr. Ho has more than 30 years of experience in the healthcare and finance industries, and has served as a venture partner of Qiming Venture Partners, a venture capital firm, since 2015, and as a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong. Dr. Ho is a retired partner of the Goldman Sachs Group, a public financial services company, where she served in several roles from 1992 to 2015, including as senior biotechnology analyst, co-head of healthcare for global investment research and advisory director for healthcare investment banking. Prior to Goldman Sachs, she held various managerial positions in licensing, strategic planning, marketing and research at DuPont-Merck Pharmaceuticals and DuPont de Nemours &amp; Company, a public chemical company, from 1982 to 1992. Dr. Ho is a member of the board of directors for various public biopharmaceutical companies, including Agios Pharmaceuticals since 2015, BioMarin Pharmaceutical since February 2021, and FibroGen since December 2018. She has also served on the board of directors for Parexel International, a private biopharmaceutical services company, from 2015 to 2017 and from March 2018 to present, as well as for two non-profit medical research organizations, the Aaron Diamond AIDS Research Center since 2005 and the Institute for Protein Innovation since 2016. Dr. Ho previously served on the board of directors for GRAIL, a private biotechnology company, from May 2019 to August 2021, when it was acquired. Dr. Ho holds a B.S. in Medical Technology and a Ph.D. in Microbiology and Immunology from the State University of New York, Downstate Medical Center. She was a postdoctoral fellow at Harvard Medical School and a graduate of the Advanced Management Program at The Fuqua School of Business at Duke University. We believe Dr. Ho is qualified to serve on our Board due to her extensive experience in healthcare investment research and banking.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Alaa Halawa</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as a member of our Board since September 2022. Mr. Halawa has served as executive director of Mubadala Capital, a venture capital firm, since March 2017. From February 2015 to March 2017, Mr. Halawa served as director at Synaptics, a public semiconductor company. Prior to that, Mr. Hawala served as director at GlobalFoundries, a public semiconductor company, from January 2014 to February 2015. Mr. Halawa currently serves on the boards of directors of several private life sciences and healthcare companies, including Alloy Therapeutics since September 2022, Innovaccer since December 2021, Xilis since July 2021 and Pretzel Therapeutics since April 2021. Mr. Halawa holds a B.A. in Electrical Engineering from University of Jordan and an M.B.A. from Cornell University. We believe Mr. Halawa is qualified to serve on our Board because of his experience as a venture capitalist and serving on boards of emerging companies that are at the intersection of life sciences and technology.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Directors Continuing in Office Until the 2026 Annual Meeting of Stockholders</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Paul L. Berns</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> is the co-founder of Neumora Therapeutics and has served as Executive Chairman since July 2023. He served as our Chief Executive Officer from November 2019 to July 2023 and as Chairman of the Board since January 2020. Mr. Berns has been a member of ARCH Venture Partners since August 2018 and became a Managing Director in 2020. Mr. Berns was a consultant to the pharmaceutical industry July 2016 to August 2018, as well as from August 2012 to March 2014 and from July 2005 to March 2006. From March 2014 to June 2016, Mr. Berns served as President, Chief Executive Officer and Chairman of the board of directors at Anacor Pharmaceuticals, a biopharmaceutical company, which was acquired by Pfizer in 2016. Previously, Mr. Berns</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">served as President and Chief Executive Officer of Allos Therapeutics, a biopharmaceutical company, from March 2006 to September 2012, when it was acquired by Spectrum Pharmaceuticals. Mr. Berns was President and Chief Executive Officer of Bone Care International, a specialty pharmaceutical company, from June 2002 to July 2005, when it was acquired by Genzyme Corporation. Prior to that, Mr. Berns was Vice President and General Manager of the Immunology, Oncology and Pain Therapeutics business unit of Abbott Laboratories from 2001 to 2002, and from 2000 to 2001 he served as Vice President, Marketing of BASF Pharmaceuticals/Knoll, until it was acquired by Abbott Laboratories in 2001. Earlier in his career, Mr. Berns held various positions, including senior management roles, at Bristol Myers Squibb from 1990 to 2000. Mr. Berns has served as a board member of the publicly held company UNITY Biotechnology since March 2018 and as chairman of the board of directors of the privately held companies Epirium Bio and HI Bio since July 2019 and August 2021, respectively. Mr. Berns has served as the chairman of the board of directors of the privately held companies Happy AI since July 2019 and NICO Therapeutics. Mr. Berns is a board member of Metsera, Ollin, and Mirador Therapeutics. Mr. Berns previously served on the boards of EQRX (from January 2020 to November 2023), Jazz Pharmaceuticals, PLC (from April 2010 to July 2021), MC2 Therapeutics (from May 2017 to January 2020), Menlo Therapeutics (from November 2017 to March 2020), Anacor Pharmaceuticals (from June 2012 to June 2016), XenoPort (from November 2005 to May 2016), Allos Therapeutics (from March 2006 to September 2012) and Bone Care International (from June 2002 to July 2005). Mr. Berns holds a B.S. in Economics from the University of Wisconsin. We believe Mr. Berns is qualified to serve on our Board because of his extensive management and leadership experience with biopharmaceutical and life sciences companies.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Matthew Fust </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has served as a member of our Board since December 2020. Mr. Fust is an advisor to life science companies and previously served as Chief Financial Officer of Onyx Pharmaceuticals, a public biopharmaceutical company, from 2009 until it was acquired by Amgen in October 2013. From October 2013 to January 2014 Mr. Fust served as Executive Vice President, Finance after Onyx Pharmaceuticals was acquired by Amgen. Prior to that, Mr. Fust held the position of Chief Financial Officer of Jazz Pharmaceuticals, a public biopharmaceutical company, from 2003 to 2008, and Chief Financial Officer of Perlegen Sciences, a private biopharmaceutical company, from 2002 to 2003. Mr. Fust previously served as Senior Vice President and Chief Financial Officer of ALZA Corporation, a public pharmaceutical company, from 1996 to 2002. Mr. Fust has served on the boards of directors of various public and private biotechnology and biopharmaceutical companies including Ultragenyx Pharmaceutical since 2014; Atara Biotherapeutics since 2014; and Crinetics Pharmaceuticals since February 2018. Mr. Fust previously served on the boards of public biotechnology and biopharmaceutical companies Dermira, from 2014 to February 2020 and MacroGenics, from 2014 to May 2020, and the private biopharmaceutical company BlackThorn from August 2017 until June 2020. Mr. Fust currently serves as an advisor to several public and private biotechnology companies. Mr. Fust holds a B.A. from the University of Minnesota and an M.B.A. from Stanford University Graduate School of Business. We believe Mr. Fust is qualified to serve on our Board because of his deep experience running and serving on the boards of biopharmaceutical companies.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">David Piacquad</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as a member of our Board since September 2023. From March 2014 through February 2022, Mr. Piacquad served as Senior Vice President, Business Development of Amgen where he was responsible for corporate strategy and business development, including external research and development, mergers &amp; acquisitions, Amgen ventures and alliance management. Prior to that Mr. Piacquad served as Vice President, Strategy and Corporate Development at Amgen from 2010 to 2014. Prior to joining Amgen, Mr. Piacquad served as Senior Vice President, Business Development &amp; Licensing at Schering-Plough Corporation, a pharmaceutical company, from 2006 to 2009. Prior to joining Schering-Plough, Mr. Piacquad served for approximately 20 years at Johnson &amp; Johnson, a pharmaceutical and medical technologies company, in increasing roles of responsibility across its business segments. Mr. Piacquad is currently an advisor to life science companies and serves as a director to various private biotechnology companies. Mr. Piacquad holds a B.A. from Colgate University and an M.B.A from the Wharton School at the University of Pennsylvania. We believe Mr. Piacquad is qualified to serve on our Board because of his extensive experience in executive strategic and business development roles within the biotechnology industry and serving on the boards of biotechnology companies.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="proposal_no_2"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PROPOSAL NO. 2</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:5.231%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND INDEPENDENT AUDITOR </font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Appointment of Independent Registered Public Accounting Firm and Independent Auditor</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Audit Committee of our Board has appointed Ernst &amp; Young LLP (&#x201c;EY&#x201d;), as our independent registered public accounting firm and independent auditor for the year ending December 31, 2024, and is seeking ratification of such selection by our stockholders at the Annual Meeting. EY has audited our financial statements for each of our fiscal years since the fiscal year ended December 31, 2019. Representatives of EY are expected to be in attendance online at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Neither our bylaws nor other governing documents or law require stockholder ratification of the selection of EY as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of EY to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain EY. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if they determine that such a change would be in the best interests of the Company and our stockholders.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principal Accountant Fees and Services</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents aggregate fees billed by EY relating to the fiscal years ended December 31, 2023 and 2022.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;"></td>
     <td style="width:1.62%;"></td>
     <td style="width:1%;"></td>
     <td style="width:12.883000000000001%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1.62%;"></td>
     <td style="width:1%;"></td>
     <td style="width:12.883000000000001%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended December 31,</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2022</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit Fees</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,306,202</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,066,891</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Audit-Related Fees</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Tax Fees</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">174,866</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">76,735</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">All Other Fees</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Fees</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,481,068</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,143,626</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;border-bottom:0.5pt solid;margin-right:5.5in;text-align:justify;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Audit fees consist of fees for professional services provided primarily in connection with the annual audit of our consolidated financial statements, quarterly reviews and services associated with SEC registration statements and other documents issued in connection with the Company&#x2019;s initial public offering including comfort letters and consents.</font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Approval Policies and Procedures</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to its charter, the Audit Committee or a delegate of the Audit Committee pre-approves all audit and non-audit services provided by its independent registered public accounting firm, unless the engagement is entered into pursuant to appropriate additional pre-approval policies established by the Audit Committee. This policy is set forth in the charter of the Audit Committee and is available at https://ir.neumoratx.com/corporate-governance/governance-overview.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Audit Committee approved all of the audit, audit -related, tax and other services provided by EY for 2023 and 2022, and, in each case, the estimated costs of those services. Actual amounts billed, to the extent in excess of the estimated amounts, are periodically reviewed and approved by the Audit Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">FOR</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RATIFICATION OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND INDEPENDENT AUDITOR.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_the_audit_committee"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">REPO</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The material in this report is not &#x201c;soliciting material,&#x201d; is not deemed &#x201c;filed&#x201d; with the SEC and is not to be incorporated by reference into any filing of Neumora under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The primary purpose of the Audit Committee is to oversee our financial reporting processes on behalf of our Board. The Audit Committee&#x2019;s functions are more fully described in its charter, which is available on our website at https://ir.neumoratx.com/corporate-governance/governance-overview. Management has the primary responsibility for our financial statements and reporting processes, including our systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management Neumora&#x2019;s audited financial statements as of and for the year ended December 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Audit Committee has discussed with Ernst &amp; Young, LLP (&#x201c;EY&#x201d;), the Company&#x2019;s independent registered public accounting firm, the matters required to be discussed by Auditing Standard 1301, Communications with Audit Committees, as adopted by the Public Company Accounting Oversight Board (the &#x201c;PCAOB&#x201d;). In addition, the Audit Committee has received the written disclosures and the letter from EY required by PCAOB Ethics and Independence Rule 3526, &#x201c;Communication with Audit Committees Concerning Independence&#x201d;, and the Audit Committee has discussed with EY their independence from the Company and its management. Finally, the Audit Committee discussed with EY, with and without management present, the scope and results of EY&#x2019;s audit of such financial statements.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on these reviews and discussions, the Audit Committee has recommended to our Board that such audited financial statements be included in our Annual Report on Form 10-K for the year ended December 31, 2023, for filing with the SEC.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Audit Committee <br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Matthew Fust, Chair<br>Kristina Burow<br>Maykin Ho, Ph.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">   </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="corporate_governance"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CORPORATE GOVERNANCE</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Code of Business Conduct and Ethics</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have adopted a Code of Business Conduct and Ethics that applies to our officers, directors and employees, which is available on our website at https://ir.neumoratx.com/corporate-governance/governance-overview. The Code of Business Conduct and Ethics contains general guidelines for conducting the business of our company consistent with the highest standards of business ethics and is intended to qualify as a &#x201c;code of ethics&#x201d; within the meaning of Section 406 of the Sarbanes-Oxley Act of 2002 and Item 406 of Regulation S-K. In addition, we intend to promptly disclose (1) the nature of any substantive amendment to our Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions and (2) the nature of any waiver, including an implicit waiver, from a provision of our code of ethics that is granted to one of these specified officers, the name of such person who is granted the waiver and the date of the waiver on our website in the future.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The reference to our web address in this proxy statement does not constitute incorporation by reference of the information contained at or available through our website.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Corporate Governance Guidelines</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe in sound corporate governance practices and have adopted formal Corporate Governance Guidelines to enhance our effectiveness. Our Board adopted these Corporate Governance Guidelines in order to ensure that it has the necessary practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The Corporate Governance Guidelines are also intended to align the interests of directors with those of our stockholders. The Corporate Governance Guidelines set forth the practices our Board follows with respect to Board and committee composition and selection, Board meetings, and succession planning. A copy of our Corporate Governance Guidelines is available on our website at https://ir.neumoratx.com/corporate-governance/governance-overview.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Independence of the Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As required under the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) rules and regulations, a majority of the members of a listed company&#x2019;s board of directors must qualify as &#x201c;independent,&#x201d; as affirmatively determined by such board. The Board consults with the Company&#x2019;s counsel to ensure that the Board&#x2019;s determinations are consistent with all relevant securities and other laws and regulations regarding the definition of &#x201c;independent,&#x201d; including those set forth in pertinent Nasdaq listing standards, as in effect from time to time.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Consistent with these considerations, our Board has determined all of our directors, other than Messrs. Berns and Gosebruch, qualify as &#x201c;independent&#x201d; directors in accordance with the Nasdaq listing requirements. Messrs. Berns and Gosebruch are not considered independent by virtue of their positions as executive officers of the company. The Nasdaq independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three years, one of our employees and that neither the director nor any of his or her family members has engaged in various types of business dealings with us. In addition, as required by Nasdaq rules, our Board has made a subjective determination as to each independent director that no relationship exists, which, in the opinion of our Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations, our Board reviewed and discussed information provided by the directors and us with regard to each director&#x2019;s business and personal activities and relationships as they may relate to us and our management. There are no family relationships among any of our directors or executive officers.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As required under Nasdaq rules and regulations, our independent directors meet in regularly scheduled executive sessions at which only independent directors are present. Each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of our Board are comprised entirely of directors determined by the Board to be independent within the meaning of Nasdaq and SEC rules and regulations applicable to the members of such committees.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Leadership Structure of the Board</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Amended and Restated Bylaws and Corporate Governance Guidelines provide our Board with flexibility to combine or separate the positions of Chairman of the Board and Chief Executive Officer and/or to implement a lead independent director in accordance with its determination that utilizing one or the other structure would be in the best interests of the Company. Mr. Gosebruch currently serves as Chief Executive Officer and President, and Mr. Berns currently serves as the Executive Chairman of our Board. In his role as Executive Chairman, Mr. Berns presides over the executive sessions of the Board and acts as a liaison between management and the Board.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board has concluded that our current leadership structure is appropriate at this time. However, our Board will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Role of Board in Risk Oversight Process</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the Board at regular Board meetings as part of management presentations that focus on particular business functions, operations or strategies and presents the steps taken by management to mitigate or eliminate such risks.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board does not have a standing risk management committee, but rather administers this oversight function directly through our Board as a whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of oversight. While our Board is responsible for monitoring and assessing strategic risk exposure, our Audit Committee is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The Audit Committee also monitors compliance with legal and regulatory requirements and considers and approves or disapproves any related person transactions. Our Nominating and Corporate Governance Committee monitors the effectiveness of our Corporate Governance Guidelines and approves or disapproves any related person transactions. Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board Committees</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board has the following standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Our Board may establish other committees to facilitate the management of our business. The composition and functions of each committee are described below.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Audit Committee</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Audit Committee oversees our corporate accounting and financial reporting process. Among other matters, the Audit Committee is responsible for:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">appointing, retaining, compensating and overseeing the work of our independent registered public accounting firm;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">assessing the independence and performance of the independent registered public accounting firm;	 </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">monitoring the rotation of partners of our independent registered public accounting firm on our engagement team as required by law;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing with our independent registered public accounting firm the scope and results of the firm&#x2019;s annual audit of our consolidated financial statements;	</font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the consolidated financial statements that we will file with the SEC;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">pre-approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing policies and practices related to risk assessment and management;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing our accounting and financial reporting policies and practices and accounting controls, as well as compliance with legal and regulatory requirements;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing, overseeing, approving, or disapproving any related-person and related party transactions;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing with our management the scope and results of management&#x2019;s evaluation of our disclosure controls and procedures and management&#x2019;s assessment of our internal control over financial reporting, including the related certifications to be included in the periodic reports we will file with the SEC; and</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls, or auditing matters, or other ethics or compliance issues.</font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The current members of our Audit Committee are Matthew Fust, Kristina Burow, and Maykin Ho, Ph.D. Mr. Fust serves as the chair of the committee. All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and Nasdaq. Our Board has determined that Mr. Fust is an audit committee financial expert as defined under the applicable rules of the SEC and has the requisite financial sophistication as defined under the applicable rules and regulations of Nasdaq. Under the rules of the SEC, members of the audit committee must also meet heightened independence standards. Our Board has determined that Mr. Fust, Ms. Burow and Ms. Ho are &#x201c;independent&#x201d; for audit committee purposes as that term is defined in the applicable rules of the SEC and Nasdaq.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Audit Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq. A copy of the Audit Committee charter is available to security holders on the Company&#x2019;s website at https://ir.neumoratx.com/corporate-governance/governance-overview.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Compensation Committee oversees policies relating to compensation and benefits of our officers and employees. Among other things, the Compensation Committee is responsible for:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and approving the compensation of our executive officers, including reviewing and approving corporate goals and objectives with respect to compensation;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">acting as an administrator of our equity incentive plans;	 	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and approving, or making recommendations to our Board with respect to, incentive compensation and equity plans;	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and recommending that our Board approve the compensation for our Chief Executive Officer and Executive Chairman; 	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reviewing and recommending that our Board approve the compensation for our non-employee board members; and 	</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">establishing and reviewing general policies relating to compensation and benefits of our employees.</font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The current members of our Compensation Committee are Kristina Burow, Matthew Fust and Alaa Halawa. Ms. Burow serves as the chair of the committee. Each of the members of our Compensation Committee is</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">independent under the applicable rules and regulations of Nasdaq, and is a &#x201c;non-employee director&#x201d; as defined in Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Compensation Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq rules. The Committee&#x2019;s charter permits it to delegate its authority and responsibilities to individual members of the Compensation Committee or to a subcommittee of Compensation Committee members, to the extent consistent with our certificate of incorporation and bylaws. A copy of the Compensation Committee charter is available to security holders on our website at https://ir.neumoratx.com/corporate-governance/governance-overview.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Compensation Committee has retained Alpine Rewards, LLC (&#x201c;Alpine&#x201d;), a national executive compensation consulting firm. Alpine was engaged to conduct market research and analysis on our various executive positions, to assist the committee in developing appropriate incentive plans for our executives on an annual basis, to provide the Compensation Committee with advice and ongoing recommendations regarding material executive compensation decisions, and to review compensation proposals proposed by management. In compliance with the proxy disclosure requirements under Regulation S-K established by the SEC regarding the independence of compensation consultants, Alpine addressed each of the six independence factors established by the SEC with the Compensation Committee. Each of the responses affirmed the independence of Alpine on executive compensation matters. Based on this assessment, the Compensation Committee determined that the engagement of Alpine does not raise any conflicts of interest or similar concerns.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Nominating and Corporate Governance Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nominating and Corporate Governance Committee is responsible for making recommendations to our Board regarding candidates for directorships and the size and composition of our Board. In addition, the Nominating and Corporate Governance Committee is responsible for overseeing our corporate governance policies and reporting and making recommendations to our Board concerning governance matters.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The current members of our Nominating and Corporate Governance Committee are Alaa Halawa, Maykin Ho, Ph.D., David Piacquad and Kristina Burow. Mr. Halawa serves as the chair of the committee. Each of the members of our Nominating and Corporate Governance Committee is an independent director under the applicable rules and regulations of Nasdaq relating to Nominating and Corporate Governance Committee independence.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq rules. A copy of the Nominating and Corporate Governance Committee charter is available to security holders on the Company&#x2019;s website page at https://ir.neumoratx.com/corporate-governance/governance-overview.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Nominating and Corporate Governance Committee is responsible for reviewing with the Board, on an annual basis, the appropriate characteristics, skills and experience required for the Board as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the Nominating and Corporate Governance Committee, in recommending candidates for election, and the Board, in approving (and, in the case of vacancies, appointing) such candidates, may take into account many factors, including but not limited to the following: 	</font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">personal and professional integrity, strong ethics, and values;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">practical and mature business judgment</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">experience in corporate management, such as serving as an officer of a public company;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">experience as a board member of another public company;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">professional and academic experience relevant to our industry;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">leadership skills; and</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">experience in finance and accounting and/or executive compensation practices.</font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Currently, our Board evaluates each individual in the context of the Board as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. For a stockholder to make any nomination for election to the Board at an annual meeting, the stockholder must provide notice to the Company, which notice must be delivered to, or mailed and received at, the Company&#x2019;s principal executive offices not less than 90 days and not more than 120 days prior to the one-year anniversary of the preceding year&#x2019;s annual meeting; provided, that if the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, the stockholder&#x2019;s notice must be delivered, or mailed and received, not later than 90 days prior to the date of the annual meeting or, if later, 10 days after the date on which public disclosure of the date of such annual meeting was first made. Further updates and supplements to such notice may be required at the times, and in the forms, required under our bylaws. As set forth in our bylaws, submissions must include the name and address of the proposed nominee, indirect and direct interests in securities of the Company, information regarding the proposed nominee that is required to be disclosed in a proxy statement or other filings in a contested election pursuant to Section 14(a) under the Exchange Act, information regarding the proposed nominee&#x2019;s indirect and direct material interests in any material contract or agreement between the nominating stockholder and any other participants in such solicitation, including, all information that would be required to be disclosure pursuant to Item 404 under Regulation S-K, and a completed and signed questionnaire, representation and agreement of the proposed nominee. Our bylaws also specify further requirements as to the form and content of a stockholder&#x2019;s notice. We recommend that any stockholder wishing to make a nomination for director review a copy of our bylaws, as amended and restated to date, which is available, without charge, from the Secretary of the Company, at 490 Arsenal Way, Suite 200, Watertown, Massachusetts.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Meetings of the Board of Directors, Board and Committee Member Attendance and Annual Meeting Attendance</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board met ten (10) times during 2023. The Audit Committee met four (4) times. The Compensation Committee met four (4) times. The Nominating and Corporate Governance Committee did not meet in 2023. During 2023, each Board member attended at least 75% of the meetings of the Board and of the committees of the Board on which he or she served, in each case, to the extent appointed as a Board member at the relevant time of each meeting. We encourage all of our directors and nominees for director to attend our annual meeting of stockholders; however, attendance is not mandatory.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stockholder Communications with the Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Should stockholders wish to communicate with the Board or any specified individual directors, such correspondence should be sent to the attention of the Secretary of the Company, 490 Arsenal Way, Suite 200, Watertown, Massachusetts. The Secretary of the Company will forward the communication to the Board members.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation Committee Interlocks and Insider Participation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During 2023, our Compensation Committee consisted of Ms. Burow, Mr. Fust and Mr. Halawa. None of the members of our Compensation Committee during 2023 nor any of the current members of our Compensation Committee has at any time been one of our officers or employees. None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers on our Board of Directors or Compensation Committee.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation Recovery (&#x201c;Clawback&#x201d;) Policy</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board has adopted the Company&#x2019;s Policy for Recovery of Erroneously Awarded Compensation (&#x201c;Clawback Policy&#x201d;), effective as of September 14, 2023, applicable to our current and former executive officers, as defined in Exchange Act Rule 10D-1(d), in accordance with SEC rules and the applicable Nasdaq listing standards. This Clawback Policy applies to incentive-based compensation that is granted, earned or vested wholly or in part upon attainment of one or more financial reporting measures (each, a &#x201c;Financial Reporting Measure&#x201d;) that is received by an executive officer (1) after beginning service as an executive officer, (2) who served as an executive officer at any time during the performance period for that compensation and (3) during the three completed fiscal</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">17</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">years immediately preceding the date on which the Company concludes, or reasonably should have concluded, that the Company is required to prepare a restatement with respect to any such Financial Reporting Measure. The Clawback Policy provides that, in the event of a restatement of our financial statements due to material noncompliance with financial reporting requirements, the administrator of the Clawback Policy will recover (subject to limited exceptions) the amount (as determined on a pre-tax basis) of incentive-based compensation erroneously received by an executive officer (i.e., in the event that the amount of such compensation was calculated based on the achievement of certain financial results that were subsequently revised due to the restatement, and the amount of the incentive-based compensation that would have been earned by such executive officer had the financial results been properly reported would have been lower than the amount actually paid).</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prohibition on Hedging, Pledging and Similar Transactions</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All employees, officers, the non-employee members of our Board and certain consultants of the Company are subject to our Insider Trading Compliance Policy. The policy prohibits the covered individuals from purchasing or selling any of our securities while in possession of material nonpublic information.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Insider Trading Compliance Policy also prohibits covered individuals, including our NEOs, from (i) making short sales of our securities, (ii) engaging in transactions in puts, calls or other options or derivative instruments related to our securities, (iii) engaging in any hedging or similar transaction designed to decrease the risks associated with holding our securities and (iv) purchasing our securities on margin or pledging our securities as collateral.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Board Diversity</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Among our seven Board members as of April 15, 2024, in accordance with Nasdaq diversity criteria, one Board member self-identifies as a woman, four Board members self-identify as white, one Board member self-identifies as Asian, and one member self-identifies as LGBTQ+.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.09%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.418%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.418%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.418%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.658%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Board Diversity Matrix as of April 15, 2024</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total Number of Directors</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="14" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Female</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Male</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Non-Binary</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Did Not<br>Disclose<br>Gender</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Part I: Gender Identity</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Directors</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Part II: Demographic Background</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">African American or Black</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alaskan Native or Native American</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Asian</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hispanic, Latino or Latinx</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Native Hawaiian or Pacific Islander</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">White</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Two or More Races or Ethnicities</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">LGBTQ+</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Did Not Disclose Demographic Background</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="transactions_with_related_persons"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TRANSACTIONS WITH R</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ELATED PERSONS</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We describe below transactions and series of similar transactions, since January 1, 2022, to which we were a party or will be a party, in which the amount involved exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed years with any of our directors, executive officers or holders of more than 5% of our common stock, or an affiliate or immediate family member thereof, had or will have a direct or indirect material interest.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Series B Convertible Preferred Stock Financing</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In September 2022, we entered into a Series B convertible preferred stock purchase agreement (&#x201c;Series B Purchase Agreement&#x201d;) with various investors, pursuant to which we issued an aggregate of 7,425,572 shares of our Series B convertible preferred stock (the &#x201c;Series B Preferred&#x201d;) at $11.77 per share for aggregate proceeds of $87.4 million in the initial closing.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In accordance with the terms of the Series B Purchase Agreement, we issued an additional 2,124,143 shares of Series B Preferred to Sapphire Direct Holdings RSC Ltd. at a fixed price of $11.77 per share for aggregate proceeds of $25.0 million in a subsequent closing in October 2022.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below sets forth the number of shares of our Series B Preferred purchased by our executive officers, directors, holders of more than 5% of our capital stock and their affiliated entities or immediate family members or issued to such parties as consideration in connection with various acquisitions of assets. Each share of Series B Preferred in the table below converted into one share of our common stock upon the completion of our initial public offering.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.98%;"></td>
     <td style="width:1.16%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.36%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1.62%;"></td>
     <td style="width:1%;"></td>
     <td style="width:12.88%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Series B<br>Convertible<br>Preferred<br>Stock<br>(#)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate<br>Purchase Price<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amgen Inc.</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">849,657</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,000,001</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Entities affiliated with ARCH Venture Partners</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,124,143</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">25,000,001</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Entities affiliated with F-Prime Capital Partners</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">84,965</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">$</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,000,001</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:5.5in;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Kristina Burow and Robert Nelsen were designated to our Board by ARCH Venture Partners. Kristina Burow is a member of our Board, and Robert Nelsen served as a member of our Board at the time of the Series B Convertible Preferred Stock Financing. In addition, our Co-Founder and Executive Chairman, Paul L. Berns, is a Managing Director of ARCH Venture Partners. For further details, see the information provided in footnote (2) to the table in the section titled &#x201c;Security Ownership of Certain Beneficial Owners and Management.&#x201d;</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Stacie Weninger, Ph.D., served as a member of our Board at the time of the Series B Convertible Preferred Stock Financing and, was designated to our Board by F-Prime Capital Partners. Dr. Weninger resigned as a director in August 2023. </font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">BlackThorn Share Issuance</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In June 2020, we entered into an agreement and plan of merger (the &#x201c;BlackThorn Merger Agreement&#x201d;) to acquire all of the equity interests of BlackThorn Therapeutics, Inc. (&#x201c;BlackThorn&#x201d;), which closed in September 2020. Pursuant to the terms of the BlackThorn Merger Agreement, we are required to pay the former equity holders of BlackThorn contingent consideration (i) with respect to navacaprant, in the form of development and regulatory approval milestones of up to an aggregate amount of $365.0 million, which includes a milestone payment that became due in October 2023 upon dosing the first patient in the Phase 3 clinical trial for navacaprant, and sales-based milestones of up to an aggregate amount of $450.0 million and (ii) with respect to NMRA-511, in the form of development and regulatory approval milestones of up to an aggregate amount of $100.0 million, and sales-based milestones of up to an aggregate amount of $100.0 million (&#x201c;BlackThorn Milestones&#x201d;). At our sole discretion, the BlackThorn Milestone payments may be settled in cash or shares of our stock, or a combination of both, subject to the provisions of the BlackThorn Merger Agreement, other than one development milestone in the amount of $10.0 million, which must be settled in cash.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, we issued 6,072,445 shares of common stock based on the volume weighted average price per share prior to the date the milestone was met and paid $2.3 million in cash in satisfaction of the Phase 3 navacaprant milestone to the former equity holders of BlackThorn and participants in the carveout plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below sets forth the cash paid or number of shares of our common stock issued to any of our directors, officers and holders of more than 5% of our capital stock and their affiliated entities in connection with the BlackThorn Milestones in December 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.967%;"></td>
     <td style="width:1.16%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.357%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1.16%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.357%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Shares of<br>Common<br>Stock<br>Issued<br>(#)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cash Paid<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Entities affiliated with ARCH Venture Partners</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,879,654</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Matthew Fust</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">132,481</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">601,538</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:5.5in;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Kristina Burow was designated to our Board by ARCH Venture Partners. Kristina Burow is a member of our Board of directors. In addition, our Co-Founder and Executive Chairman, Paul L. Berns, is a Managing Director of ARCH Venture Partners. For further details, see the information provided in footnote (2) to the table in the section titled &#x201c;Security Ownership of Certain Beneficial Owners and Management.&#x201d;</font></div></div><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Represents the portion of the payment that was payable in respect of equity grants that vested while such individual was providing services to BlackThorn and that is considered contingent consideration of the BlackThorn acquisition.</font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amgen Agreements</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amgen Inc., one of our greater than 5% stockholders, is party to two license agreements and a research and collaboration agreement with us as described in our Annual Report on Form 10-K for the year ended December 31, 2023 under &#x201c;Business&#x2014;In-Licensing and Collaboration Agreements&#x2014;Exclusive License Agreements with Amgen for CK1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;min-width:fit-content;">d</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and GCase&#x201d; and &#x201c;Business&#x2014;In-Licensing and Collaboration Agreements&#x2014;Research Collaboration Agreement with Amgen&#x201d;. During the years ended December 31, 2023 and 2022, we made payments to Amgen of $21.9 million $25.0 million, respectively, under the Amgen Collaboration Agreement. No payments were made during the three-months ended March 31, 2024 and a $6.3 million non-refundable quarterly payment became due as of March 31, 2024.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Investors&#x2019; Rights Agreement</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are party to an amended and restated investors&#x2019; rights agreement with certain holders of our common stock, including entities with which certain of our directors are affiliated. Under this agreement, the holders of certain shares of our common stock are entitled to rights with respect to the registration of their shares under the Securities Act. The amended and restated investors&#x2019; rights agreement also provided for a right of first offer in favor of certain of our stockholders. The rights of first offer terminated upon the consummation of our initial public offering. The amended and restated investors&#x2019; rights agreement is filed as an exhibit to our Annual Report on 10-K for the year ended December 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Director and Executive Officer Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See &#x201c;Executive Compensation&#x201d; and &#x201c;Director Compensation&#x201d; for information regarding compensation of directors and executive officers.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Employment Agreements</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have entered into employment agreements with certain of our named executive officers. For more information regarding these agreements, see &#x201c;Executive Compensation&#x2013;Narrative to Summary Compensation Table.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Director and Officer Indemnification and Insurance</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things, require us to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#x2019; fees, judgments, penalties, fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the person&#x2019;s services as a director or executive officer. We have obtained an insurance policy that insures our directors and officers against certain liabilities, including liabilities arising under applicable securities laws.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Policies and Procedures for Related Party Transactions</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board has adopted a written related person transaction policy setting forth the policies and procedures for the review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act of 1933, as amended, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. In reviewing and approving any such transactions, our Audit Committee is tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#x2019;s length transaction with an unrelated third party and the extent of the related person&#x2019;s interest in the transaction.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">21</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="director_compensation"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DIRECTOR COMPENSATION</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth information concerning the compensation earned by our non-employee directors during the year ended December 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 Director Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:34.493%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.177%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.177%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.177%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:13.977%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fees Earned or Paid in Cash<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option Awards<br>($)</font><font style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Non-Equity Incentive Plan Compensation<br>($)</font><font style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;position:relative;min-width:fit-content;">(6)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Kristina Burow</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">66,590</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">620,007</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">686,597</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Matthew Fust</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">67,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">375,969</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,065</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">485,534</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alaa Halawa</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51,189</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">620,007</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">671,196</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Maykin Ho, Ph.D.</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">55,000</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">375,969</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">430,969</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">David Piacquad</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">618,260</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">620,760</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Robert Nelsen</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(3)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">K&aacute;ri Stef&aacute;nsson</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(4)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32,656</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">32,656</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stacie Weninger</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(5)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46,889</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">862,920</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">909,809</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.75pt solid #000000;margin-right:5.5in;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Amounts represent the grant date fair value of the option granted or, in the case of Dr. Weninger, the incremental fair value of the options modified, during 2023 as calculated in accordance with FASB ASC Topic 718. See Financial Accounting Standards Board, Accounting Standards Codification Topic 718, </font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation&#x2014;Stock Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">. Assumptions used in the calculation of these amounts are described in Note 11 to our consolidated financial statements included in our Form 10-K for the fiscal year ended December 31, 2023.  As of December 31, 2023, held options to purchase the following number of shares of our common stock: Dr. Burow, 46,455; Mr. Fust, 135,176; Mr. Halawa, 46,455; Dr. Ho, 123,388; Mr. Piacquad, 46,455 and Ms. Weninger 95,586. None of our non-employee directors held stock awards as of December 31, 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Piacquad was appointed to our Board in September 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Nelsen resigned from our Board in September 2023. </font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Ms. Stef&aacute;nsson resigned from our Board in September 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Dr. Weninger resigned from our Board in August 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">As an equity holder of BlackThorn, Mr. Fust received a cash payment under the RBNC Therapeutics, Inc. Milestone Carveout Plan (the &#34;Carveout Plan&#34;) associated with the milestone payment for for NMRA-140 described below. Amount reflects the portion of the payment that vested during Mr. Fust's service as a director on our Board.</font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Narrative to Director Compensation Table</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior to our initial public offering, we did not maintain a formalized non-employee director compensation program, but we did pay cash compensation of $10,000 per quarter to Mr. Fust and Dr. Ho and granted our non-employee directors who were not affiliated with our investors stock options in connection with their appointment to our Board. As a former non-employee director of BlackThorn, an entity we acquired in September 2020, Mr. Fust participates in the Carveout Plan pursuant to which former holders of options to purchase BlackThorn common stock are eligible to receive milestone payments upon (i) dosing the first patient in the Phase 3 clinical trial for an antagonist of the Kappa Opioid Receptor (NMRA-140) for the treatment of major depressive disorders and achievement of certain sales-based milestones related to NMRA-140 and (ii) achievement of development and regulatory approval milestones, as well as sales-based milestones, with respect to an antagonist of the Vasopressin 1a Receptor (NMRA-511) for the treatment of anxiety disorders. A portion of those payments are contingent upon continued service on our board of directors and that portion of the payment is considered director compensation. Accordingly, during 2023 Mr. Fust received $42,065 in non-equity incentive plan compensation under the Carveout Plan as a result of dosing the first patient in the Phase 3 clinical trial for NMRA-140.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Dr. Weninger&#x2019;s resignation from our board of directors, we accelerated the vesting of her stock options and provided her up to 18 months to exercise her stock options.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, at the closing of the initial public offering of our common stock (&#x201c;IPO&#x201d;), on September 14, 2023, we granted options to each of our non-employee directors whose service on our Board continued following the IPO. We granted an option to purchase 46,455 shares of our common stock to Ms. Burow, Mr. Halawa and Mr. Piacquad and an option to purchase 27,802 shares of our common stock to Mr. Fust and Dr. Ho. Each option has an exercise per share equal to $17, which was the offer price to the public in our IPO. The option granted to each of Ms. Burow, Mr. Halawa and Mr. Piacquad vest as to 1/36</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the number of shares subject to the option on each</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">monthly anniversary of September 14, 2023, and the option granted to each of Mr. Fust and Dr. Ho vests on the date of this annual meeting of stockholders.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commencing on the closing of our IPO and after giving effect to the stock option grants described above, our non-employee directors are compensated under the Company&#x2019;s Non-Employee Director Compensation Program (the &#x201c;Director Compensation Program&#x201d;). As in effect at the closing of our IPO, the Director Compensation Program provided for our non-employee directors to receive cash compensation as follows:</font></p><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each non-employee director will receive an annual cash retainer in the amount of $40,000.</font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The lead independent director will receive additional cash compensation in the amount of $25,000 per year.</font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The chair and each member of the audit committee will receive additional cash compensation in the amount of $20,000 and $10,000 per year, respectively, for service on the audit committee.</font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The chair and each member of the compensation committee will receive additional cash compensation in the amount of $15,000 and $7,500 per year, respectively, for service on the compensation committee.</font></div></div><div style="margin-left:0.25in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.9998336002662396%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The chair and each member of the nominating and corporate governance committee will receive additional cash compensation in the amount of $10,000 and $5,000 per year, respectively, for service on the nominating and corporate governance committee.</font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each non-employee director may elect, on an annual basis, to convert all or a portion of such non-employee director&#x2019;s annual retainer into a number of restricted stock units granted under the 2023 Plan, which will be fully vested on the date of grant, and settlement of the restricted stock units may be deferred at the election of the non-employee director.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Director Compensation Program, each non-employee director who is initially elected or appointed to serve on our Board on or after the effective date of the Director Compensation Program will automatically be granted an option (the &#x201c;Initial Grant&#x201d;) under the 2023 Plan to purchase that number of shares of our common stock equal to (i) $600,000, divided by (ii) the per share grant date fair value of the option award. The Initial Grant will vest as to 1/36th of the underlying shares on a monthly basis over three years, subject to continued service through the applicable vesting date. In addition, on the date of each annual meeting of our stockholders following the completion of this offering, each non-employee director who (i) has been serving on our Board for at least four months and (ii) will continue to serve as a non-employee director immediately following such annual meeting will automatically be granted an option (the &#x201c;Annual Grant&#x201d;) under the 2023 Plan to purchase that number of shares of our common stock equal to (i) $350,000, divided by (ii) the per share grant date fair value of the option award. The Annual Grant will vest in full on the earlier of the (i) first anniversary of the grant date, and (ii) immediately prior to the annual meeting of our stockholders following the date of grant, subject to continued service through the applicable vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Director Compensation Program, upon a change in control transaction, all outstanding equity awards held by our non-employee directors will vest in full.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Director Compensation Program, we also reimburse each non-employee director for all reasonable business expenses incurred in the performance of such non-employee director&#x2019;s duties.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2024, we amended our Director Compensation Program to increase the annual retainer payable to our non-employee directors for service on our board of directors to $45,000. The amended Director Compensation Program also provides for the Initial Grant to be comprised of a stock option and award of restricted stock units (&#x201c;RSUs&#x201d;) with an aggregate grant date fair value of $725,000. The number of shares underlying the stock option is determined by dividing $362,500 by the per share grant date fair value of the option, rounded down, and the number of RSUs is determined by dividing $362,500 by the closing trading price of a share of our common stock on the date of grant (or immediately preceding trading day if the date of grant is not a trading day), rounded down. The stock option has an exercise price per share equal to the closing trading price of a share of our common stock on the date of grant (or immediately preceding trading day if the date of grant is not a trading day) and vests as to 1/36th of the underlying shares on a monthly basis over three years, subject to continued service through the applicable vesting</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">date. The RSUs vest in substantially equal installments on each of the first three anniversaries of the date of grant, subject to continued service through the applicable vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the amended Director Compensation Program provides for the Annual Grant to be comprised of a stock option and award of RSUs with an aggregate grant date fair value of $400,000. The number of shares underlying the stock option is determined by dividing $200,000 by the per share grant date fair value of the option, rounded down, and the number of RSUs is determined by dividing $200,000 by the closing trading price of a share of our common stock on the date of grant (or immediately preceding trading day if the date of grant is not a trading day), rounded down. The stock option has an exercise price per share equal to the closing trading price of a share of our common stock on the date of grant (or immediately preceding trading day if the date of grant is not a trading day) and each of the stock option and the RSUs vest in a single installment on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders after the date of grant.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">24</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="executive_officers"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIVE OFFICERS</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is biographical information for our executive officers, including their ages as of April 15, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:44%;"></td>
     <td style="width:1%;"></td>
     <td style="width:10%;"></td>
     <td style="width:1%;"></td>
     <td style="width:44%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;text-align:right;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:left;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Age</font></p></td>
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:top;text-align:right;"><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Position</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">57</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Executive Chairman</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Robert Lenz, M.D., Ph.D.</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">53</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Head of Research and Development</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason Duncan</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Legal Officer</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Daljit (Bill) Singh Aurora, Pharm.D.</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">56</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Strategy Officer</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Joshua Pinto, Ph.D.</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Carol Suh</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Operating Officer</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The biographical information of Mr. Gosebruch and Mr. Berns are included above under &#x201c;Proposal No. 1 Election of Directors.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Robert Lenz, M.D., Ph.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as our Head of Research &amp; Development since September 2023. From November 2012 to September 2023, Dr. Lenz was at Amgen, a public biopharmaceutical company, where he most recently served as Senior Vice President, Global Development from May 2020 to September 2023 and as Vice President, head of Center for Design and Analysis, Inflammation, Neurology and Nephrology Development Franchise Head from November 2018 to May 2020. Previously, Dr. Lenz held roles within clinical development at Abbott Laboratories from June 2004 to November 2012, most recently serving as Divisional Vice President, Neuroscience, Anesthesia, Psychiatry Development from January 2011 to November 2012. Dr. Lenz holds an M.D. and a Ph.D. from the University of Maryland, with a research focus in Neuropharmacology. He completed his residency in Neurology at the University of California, Los Angeles.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Jason Duncan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> has served as our Chief Legal Officer since December 2023. Prior to joining Neumora, he served as chief legal officer, general counsel and secretary of Albireo Pharma, a publicly traded biotech company that was acquired by Ipsen in 2023. Prior to Albireo, Mr. Duncan served as general counsel, Americas at Stallergenes Greer Holdings from August 2015 to June 2018. Previously, Mr. Duncan was vice president, head of compliance and legal, North America at Sobi, Inc., a global biopharmaceutical company, from May 2014 to August 2015. Mr. Duncan holds a J.D. from Suffolk University Law School and a B.A. in Political Science from Dickinson College.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Bill Aurora, Pharm.D. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has served as our Chief Strategy Officer since September 2023. He held prior roles that include Chief Development Officer and Chief External Affairs Officer since joining Neumora in August 2021. From July 2016 to June 2021, Dr. Aurora served as the chief scientific affairs officer of Dermira, Inc., which was acquired by Eli Lilly in 2020. Previously, he held vice president roles in medical affairs at Neurocrine Biosciences from May 2015 to July 2016 and global scientific affairs at Merck Research Laboratories from September 2014 to April 2015 and Amgen from July 2002 to September 2014. Dr. Aurora holds a Pharm.D. from the University of Texas Health Science Center, San Antonio, and B.S. in pharmacy from the University of Texas at Austin. He obtained board certification in psychiatric pharmacy practice.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Joshua Pinto, Ph.D. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">has served as our Chief Financial Officer since June 2021. Prior to Neumora, Dr. Pinto held roles of increasing responsibility at Credit Suisse, a public financial services company, from April 2015 to June 2021, most recently serving as director of healthcare investment banking from January 2019 to June 2021, where he focused on the life sciences sector and was responsible for advising biotech companies on mergers, acquisitions, restructurings, activism and financing. Dr. Pinto worked for Piper Jaffray, a financial services company, as an associate in healthcare banking from 2014 to 2015. Before that, he worked in global external R&amp;D at Eli Lilly, a public pharmaceutical company, from 2013 to 2014. Dr. Pinto holds a B.S. in Business Administration and Biochemistry from Centenary College of Louisiana, an M.B.A. in Finance from McMaster University and a Ph.D. in Neuroscience from McMaster University.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">25</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Carol Suh</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> is one of our co-founders and has served as our Chief Operating Officer since January 2023. From January 2022 through January 2023, she served as our Senior Vice President, Strategy and from January 2020 through December 2021 served as our Vice President of Business Development. Ms. Suh has been a member of ARCH Venture Partners, a venture capital firm focused on early-stage technology companies, since August 2018 and became a Partner in July 2021. While at ARCH, she has been involved in company creation and helped build multiple biotechnology companies across several therapeutic areas. Ms. Suh is a co-founder of Orbital Therapeutics, a private biotechnology company, since March 2022 and has served on its board of directors since August 2022. She has served on the board of directors of HI-Bio, a private biotechnology company, since August 2021 and the Metrodora Foundation, a not-for-profit medical research institute, since October 2021. Prior to ARCH, Ms. Suh helped launch Magenta Therapeutics, previously a public biotechnology company, in 2016 and served as Business Development and Corporate Strategy Associate from June 2017 to September 2017. Previously, she was a consultant at Trinity Partners, a consulting company, from 2015 to 2016. Ms. Suh began her career in R&amp;D strategy with the Regenerative Medicine group of GlaxoSmithKline, a public pharmaceutical company, in 2014. Ms. Suh holds an A.B. in Molecular and Cellular Biology from Harvard University, where she trained under Dr. David Scadden at the Harvard Stem Cell Institute, an M.Phil. from Yale University, where she was awarded the National Science Foundation Graduate Research Fellowship for her work in stem cell biology, and an M.B.A. from Stanford Graduate School of Business.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="executive_compensation"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXECUTIVE COMPENSATION</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following is a discussion and analysis of compensation arrangements of our named executive officers, or NEOs. This discussion contains forward looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt may differ materially from currently planned programs as summarized in this discussion. As an &#x201c;emerging growth company&#x201d; as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We seek to ensure that the total compensation paid to our executive officers is reasonable and competitive. Compensation of our executives is structured around the achievement of individual performance and near-term corporate targets as well as long-term business objectives.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our NEOs for fiscal year 2023 are as follows:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Henry O. Gosebruch, our President and Chief Executive Officer; </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul L. Berns, our Co-Founder, Executive Chairman and former Chief Executive Officer;</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rob Lenz, our Head of Research and Development; and</font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jason Duncan, our Chief Legal Officer. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2023, in connection with the appointment of Mr. Gosebruch as our President and Chief Executive Officer, Mr. Berns transitioned to serve as our Executive Chairman.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 Summary Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth total compensation paid to our named executive officers for the year ending on December 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:19.36%;"></td>
     <td style="width:1%;"></td>
     <td style="width:3.82%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:7.18%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:6.4%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:7.18%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:7.18%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.52%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:8.74%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:8.62%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name and Principal Position</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Salary<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Bonus<br>($)</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Stock<br>Awards<br>($)</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Awards<br>($)</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(3)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Non-Equity<br>Incentive Plan<br>Compensation<br>($)</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(4)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">All Other<br>Compensation<br>($)</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;position:relative;min-width:fit-content;">(5)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total ($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch </font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-size:4.355pt;position:relative;min-width:fit-content;">(6)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">337,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,520,250</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,739,983</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14,929,223</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">465,750</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,563</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,999,269</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">President and Chief<br>&#160;&#160;&#160;Executive Officer</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-size:4.355pt;position:relative;min-width:fit-content;">&#160;(7)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">537,500</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">16,125</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,922,080</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,082,737</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,826</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,570,268</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Executive Chairman<br>&#160;&#160;&#160;and former<br>&#160;&#160;&#160;Chief Executive Officer</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2022</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">570,000</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,755,346</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">308,798</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">780</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,634,924</font></p></td>
     <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason Duncan </font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-size:4.355pt;position:relative;min-width:fit-content;">(8)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26,250</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,093,730</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,119,980</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Chief Legal Officer</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rob Lenz </font><font style="color:#000000;top:-3.0485pt;white-space:pre-wrap;font-size:4.355pt;position:relative;min-width:fit-content;">(9)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">169,231</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">504,201</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,009,350</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,803,239</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">96,632</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,582,881</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Head of Research and<br>&#160;&#160;&#160;Development</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:6.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:5.5in;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$2,500,000 and $500,000 of the amounts represent sign-on bonuses paid to Mr. Gosebruch and Mr. Lenz, respectively. The remainder of the amount reported for the NEOs represents a discretionary adjustment made to annual cash incentive bonuses earned by our NEOs based on our compensation committee&#x2019;s and board of director&#x2019;s assessment of overall corporate performance for 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Amounts represent the aggregate grant date fair value of restricted stock awards and restricted stock units granted in 2023 computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are described in Note 11 to our consolidated financial statements included in our Form 10-K for the fiscal year ended December 31, 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Amounts represent the aggregate grant date fair value of stock options and stock purchase rights granted in 2023 computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are described in Note 11 to our consolidated financial statements included in our Form 10-K for the fiscal year ended December 31, 2023.  </font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$711,862 of the amount reported for Mr. Berns represents a cash payment under the Carveout Plan. Such amount reflects the portion of the payment that vested during Mr. Berns&#x2019; service to our company as an executive officer and a director on our Board. The remaining amounts represent annual cash incentive bonuses earned by our NEOs based on the achievement of certain pre-established metrics under our 2023 Bonus Plan, as described in the section below titled &#x201c;2023 Bonuses.&#x201d; </font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">27</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Amounts reported for 2023 are comprised of 401(k) Plan matching contributions, electronics allowance and gifts of consumer goods as follows:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:30.886%;"></td>
     <td style="width:1%;"></td>
     <td style="width:15.163%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:15.163%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:15.163%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:15.623%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">401(k) Plan<br>Matching<br>Contributions</font></p></td>
     <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Electronics<br>Allowance</font></p></td>
     <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Gift</font></p></td>
     <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</font></p></td>
     <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="border-right:0.5pt solid #000000;text-indent:5pt;white-space:pre-wrap;border-left:0.5pt solid #000000;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
     <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,726</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">390</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,447</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,563</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="border-right:0.5pt solid #000000;text-indent:5pt;white-space:pre-wrap;border-left:0.5pt solid #000000;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font></p></td>
     <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,900</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">780</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,146</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,826</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="border-right:0.5pt solid #000000;text-indent:5pt;white-space:pre-wrap;border-left:0.5pt solid #000000;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rob Lenz</font></p></td>
     <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">228</font></p></td>
     <td style="border-right:0.5pt solid #000000;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Gosebruch commenced employment with us as our President and Chief Executive Officer in July 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Berns ceased serving as our President and Chief Executive Officer and transitioned to serve as the Executive Chairman of our Board in July 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Duncan commenced employment with us as our Chief Legal Officer in December 2023.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Mr. Lenz commenced employment with us in September 2023. </font></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Narrative to Summary Compensation Table</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2023 Salaries</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our NEOs each receive a base salary to compensate them for services rendered to our company. The base salary payable to each NEO is intended to provide a fixed component of compensation reflecting the NEO&#x2019;s skill set, experience, role and responsibilities. For 2023, Mr. Gosebruch, Mr. Berns, Mr. Duncan, and Mr. Lenz had an annual base salary of $675,000, $625,000, $455,000, and $550,000, respectively. In connection with Mr. Berns&#x2019; transition to Executive Chairman of our Board in July 2023, his annual base salary was reduced to $450,000.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Board and Compensation Committee may adjust base salaries from time to time in their discretion.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2023 Bonuses</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain an annual performance-based cash bonus program in which each of our NEOs participated in fiscal year 2023. Each NEO&#x2019;s target bonus is expressed as a percentage of their annual base salary which can be achieved by meeting company and individual goals at target level. The 2023 annual bonuses for Mr. Gosebruch, Mr. Berns, and Mr. Lenz were targeted at 60%, 60%, and 50% of their respective base salaries. Mr. Gosebruch&#x2019;s target bonus was not pro-rated for 2023. Mr. Berns&#x2019; and Mr. Lenz&#x2019;s were pro-rated based on base salary earned during 2023. Mr. Duncan&#x2019;s target bonus was established at 40% of his base salary in connection with his commencement of employment with us in December 2023; however, he was not eligible to receive a bonus in 2023. Our Board has historically reviewed these target percentages to ensure they are adequate but does not follow a formula. Instead, our Board set these rates based on each NEO&#x2019;s experience in their role with us and the level of responsibility held by the NEO, which we believe directly correlates to their ability to influence corporate results.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For determining performance bonus amounts, our Board set certain corporate performance goals after receiving input from our Chief Executive Officer. Messrs. Gosebruch&#x2019;s and Berns&#x2019; bonuses are based 100% on the achievement of our corporate goals and our other NEOs&#x2019; bonuses are based 75% on the achievement of our corporate goals and 25% on individual performance.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In early 2024, our Compensation Committee determined that the corporate goals under our 2023 performance-based cash bonus program were achieved at 115%, which it, in conjunction with our full board of directors, increased to 120% based on its determination of performance factors not originally included as goals under the bonus program. Our compensation committee also assessed the individual performance of Mr. Lenz. The actual amounts paid to our named executive officers are set forth in the Summary Compensation Table above under the column &#x201c;Non-Equity Incentive Plan Compensation.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prior to our acquisition of BlackThorn in September 2020, Mr. Berns served as Executive Chairman of BlackThorn. In his capacity as Executive Chairman of BlackThorn, Mr. Berns was granted an option to purchase shares of BlackThorn common stock and became a participant in the Carveout Plan at the closing of our acquisition of BlackThorn. The Carveout Plan provides former holders of options to purchase BlackThorn common stock to be eligible to receive milestone payments upon (i) dosing the first patient in the Phase 3 clinical trial for an antagonist of the Kappa Opioid Receptor (NMRA-140) for the treatment of major depressive disorders and achievement of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">28</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">certain sales-based milestones related to NMRA-140 and (ii) achievement of development and regulatory approval milestones, as well as sales-based milestones, with respect to an antagonist of the Vasopressin 1a Receptor (NMRA-511) for the treatment of anxiety disorders. A portion of those payments are contingent upon continued service to our company and that portion of the payment is reflected here as compensation. Accordingly, during 2023 Mr. Berns received $711,862 in non-equity incentive compensation under the Carveout Plan as a result of dosing the first patient in the Phase 3 clinical trial for NMRA-140.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mr. Gosebruch was provided a sign on bonus in the amount of $2,500,000 in connection with his commencement of employment with us as our President and Chief Executive Officer in July 2023. The sign on bonus must be repaid in full if Mr. Gosebruch&#x2019;s employment with us is terminated prior to July 2025 for any reason other than a termination by us without cause, by Mr. Gosebruch for good reason or as a result of death or disability.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mr. Lenz was also provided a sign on bonus in the amount of $500,000 in connection with his commencement of employment with us as our Head of Research and Development in September 2023. The sign on bonus must be repaid in full, net of taxes, if Mr. Lenz&#x2019;s employment with us is terminated prior to September 2025 for any reason other than a termination by us for cause, by Mr. Lenz for good reason or as a result of death or disability.</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity-Based Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Mr. Berns&#x2019; transition to serve as our Executive Chairman in July 2023, we granted Mr. Berns an option to purchase 955,864 shares of our common stock, with an exercise price per share of $6.36, that vests as to 25% of the shares underlying the option on July 3, 2024 and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Mr. Gosebruch&#x2019;s commencement of employment with us in July 2023 as our President and Chief Executive Officer, we granted Mr. Gosebruch an option to purchase 2,039,177 shares of our common stock for $6.36 per share. Mr. Gosebruch&#x2019;s option vests as to 25% of the shares underlying the option on July 3, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We also granted Mr. Gosebruch the right to purchase 127,448 fully vested shares of our common stock, the stock purchase right, for $6.36 per share and a restricted stock award covering 382,345 shares of our common stock if Mr. Gosebruch exercised the stock purchase right in full. In July 2023, Mr. Gosebruch exercised his stock purchase right in full and, in turn, a matching restricted stock award was granted covering 382,345 shares of our common stock, all of which were subject to a risk of forfeiture upon certain terminations of Mr. Gosebruch&#x2019;s employment. The risk of forfeiture lapses as to 25% of the shares underlying the restricted stock award on July 3, 2024, and as to 1/48th of the original number of shares underlying the restricted stock award each month thereafter, subject to continued service to us.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Mr. Lenz&#x2019;s commencement of employment with us as our Head of Research and Development, we granted Mr. Lenz an option to purchase 502,934 shares of our common stock for an exercise price of $17.00 per share. Mr. Lenz&#x2019;s option vests as to 25% of the shares underlying the option on September 11, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date. We also granted Mr. Lenz an award of 352,941 restricted stock units. Each restricted stock unit represents the right to be issued a share of our common stock following vesting.  The restricted stock units vest in substantially equal installments on the first four anniversaries of September 11, 2023, subject to continued service to us through the vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Mr. Duncan&#x2019;s commencement of employment with us as our Chief Legal Officer, we granted Mr. Duncan an option to purchase 400,000 shares of our common stock for an exercise price of $12.97 per share. Mr. Duncan&#x2019;s option vests as to 25% of the shares underlying the option on December 11, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">29</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Elements of Compensation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Retirement Savings and Health and Welfare Benefits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We currently maintain a 401(k) retirement savings plan for our employees, including our named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time employees. During 2023, we matched 50% of up to 6% of employee, including NEO, compensation that is contributed to our 401(k) plan, up to plan limits.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All of our full-time employees, including our NEOs, are eligible to participate in our health and welfare plans, including medical, dental and vision benefits; medical and dependent care flexible spending accounts; short-term and long-term disability insurance; and life and AD&amp;D insurance. Our NEOs are eligible for certain enhanced benefits under our executive-level medical insurance, life insurance and short-term and long-term disability insurance.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Perquisites and Other Personal Benefits</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We provide each of our NEOs an electronics allowance of $780 per year. During 2023, we also provided our NEOs gifts comprised of leather bags.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2023, in connection with Mr. Gosebruch&#x2019;s commencement of employment with us as our President and Chief Executive Officer, Mr. Gosebruch is entitled to be reimbursed for legal fees incurred in negotiating his employment agreement with us. No such legal fees were reimbursed in 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our compensation committee may from time to time approve perquisites in the future when our compensation committee determines that they are necessary or advisable to fairly compensate or incentivize our employees.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding Equity Awards at 2023 Fiscal Year-End</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table lists all outstanding equity awards held by our NEOs as of December 31, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:14.52%;"></td>
     <td style="width:1%;"></td>
     <td style="width:12.44%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.5%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:11%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:5.54%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.42%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:9.68%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1.48%;"></td>
     <td style="width:1%;"></td>
     <td style="width:10.42%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="13" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option Awards</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Stock Awards</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:7pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Vesting<br>Commencement<br>Date</font><font style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br>Securities<br>Underlying<br>Unexercised<br>Options (#)<br>Exercisable</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of<br>Securities<br>Underlying<br>Unexercised<br>Options (#)<br>Unexercisable</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Exercise<br>Price<br>($)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Option<br>Expiration<br>Date</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of <br>Shares or<br>Units of Stock <br>That Have <br>Not Vested<br>(#)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Market Value <br>of Shares or <br>Units of Stock <br>That Have <br>Not Vested<br>($)</font><font style="color:#000000;top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/3/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,039,177</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.36</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/2/2033</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/12/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">382,345</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,518,982</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7/3/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">955,864</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.36</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">06/27/2033</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2/1/2022</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">227,814</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">269,235</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.63</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1/26/2032</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1/17/2020</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">132,759</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-size:5.36pt;position:relative;min-width:fit-content;">(3)</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,263,541</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11/1/2018</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">88,707</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.83</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9/7/2030</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason Duncan</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12/11/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">400,000</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.97</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12/10/2033</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Rob Lenz</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9/11/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">502,934</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.00</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9/13/2033</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9/11/2023</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">352,941</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;top:-3.752pt;white-space:pre-wrap;font-size:5.36pt;position:relative;min-width:fit-content;">(4)</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,017,644</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:5.5in;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="display:flex;margin-top:2pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Except as otherwise noted, each option award vests and becomes exercisable and each stock award vests as to 25% of the underlying shares on the first anniversary of the vesting commencement date and as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date thereafter, in each case, subject to continued service to us. </font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Market value based on $17.05 per share, the closing trading price of our common stock as of December 29, 2023, the last trading day in 2023. </font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Constitutes restricted shares of our common stock acquired upon exercise of a stock purchase right that remain subject to repurchase by us at their original purchase price of $0.0001 per share. The restricted shares vest and our repurchase right lapses in full on January 17, 2024, subject to continued service with us.</font></div></div><div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Constitutes an award of restricted stock units that vests in substantially equal annual installments through the fourth anniversary of the vesting commencement date, subject to continued service with us.</font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Executive Compensation Arrangements</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have entered into employment agreements and proprietary information and invention assignment agreements with each of our NEOs. Each employment agreement sets forth the title, base salary, target bonus opportunity and initial equity award for the NEO.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2023, we entered into an Executive Employment Agreement with Mr. Gosebruch setting forth the terms and conditions of Mr. Gosebruch&#x2019;s employment with us as our President and Chief Executive Officer. The Executive Employment Agreement provides for Mr. Gosebruch to be paid an annual base salary of $675,000 and an annual bonus targeted at 60% of Mr. Gosebruch&#x2019;s base salary. The Executive Employment Agreement also provided for Mr. Gosebruch to be paid a sign on bonus in the amount of $2,500,000 that must be repaid in full if Mr. Gosebruch&#x2019;s employment with us is terminated prior to July 2025 for any reason other than a termination by us without cause, by Mr. Gosebruch for good reason or as a result of death or disability, in each case, as defined in the Executive Employment Agreement.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the Executive Employment Agreement provided for the grant to Mr. Gosebruch of an option to purchase 2,039,177 shares of our common stock for $6.36 per share, which our Board determined was equal to the fair market value of a share on the date of grant. Mr. Gosebruch&#x2019;s option vests as to 25% of the shares underlying the option on July 3, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date. The Executive Employment Agreement also provided for the grant to Mr. Gosebruch of a stock purchase right covering 127,448 fully vested shares of our common stock for $6.36 per share, which our Board determined was equal to the fair market value of a share on the date of grant and a restricted stock award covering 382,345 shares of our common stock if Mr. Gosebruch exercised the stock purchase right in full. In July 2023, Mr. Gosebruch exercised his stock purchase right in full and, in accordance with the Executive Employment Agreement, the restricted stock award was granted covering 382,345 shares of our common stock, all of which were subject to a risk of forfeiture upon certain terminations of Mr. Gosebruch&#x2019;s employment. The risk of forfeiture lapses as to 25% of the shares underlying the restricted stock award on July 3, 2024, and as to 1/48th of the original number of shares underlying the restricted stock award each month thereafter, subject to continued service to us through the applicable vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Executive Employment Agreement, Mr. Gosebruch is eligible to receive severance in the event his employment with us is terminated by us without cause or by him for good reason. In the event the qualifying termination occurs more than 3 months prior to or more than 12 months after a change in control, as defined in the Executive Employment Agreement, Mr. Gosebruch is entitled to receive 12 months continued base salary, his target bonus opportunity, up to 12 months of continued health-care coverage or COBRA reimbursements and solely in the event of a termination by us without cause, extended exercisability of any portion of the initial stock option granted to Mr. Gosebruch that is vested and outstanding as of the date of termination through the earliest of the (i) the 10 year anniversary of the stock option grant, (ii) the nine-month anniversary of this offering, or (iii) immediately prior to a change in control. In the event the qualifying termination occurs within the period beginning 3 months prior to and ending 12 months after a change in control, Mr. Gosebruch is entitled to 24 months of base salary, two times his target annual bonus opportunity, continued healthcare coverage or COBRA reimbursements for up to 24 months and full vesting acceleration of all equity awards. Mr. Gosebruch must provide a general release of claims in order to receive severance benefits.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Executive Employment Agreement also provided for us to reimburse Mr. Gosebruch up to $20,000 for legal fees incurred in negotiating the Executive Employment Agreement.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2022, we entered an Executive Employment Agreement with Mr. Berns that provided for Mr. Berns to receive severance in the event his employment with us was terminated by us without cause or by him for good reason, each as defined in the Executive Employment Agreement. In the event the qualifying termination occurs more than 3 months prior to or more than 18 months after a change in control, as defined in the Executive Employment agreement, Mr. Berns is entitled to receive 12 months continued base salary and up to 12 months of continued health-care coverage or COBRA reimbursements. In the event the qualifying termination occurs within the period beginning 3 months prior to and ending 18 months after a change in control, Mr. Berns is entitled to a lump sum payment of 12 months base salary and his target bonus opportunity, continued healthcare coverage or COBRA reimbursements for up to 18 months and full vesting acceleration of all equity awards. Mr. Berns must provide a general release of claims in order to receive severance benefits.</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Mr. Berns&#x2019; transition to the role of Executive Chairman in July 2023, we entered into an Executive Chairman Agreement with him that superseded the employment agreement described above. Under the Executive Chairman Agreement, Mr. Berns will be paid an annual base salary of $450,000 and be eligible for an annual bonus targeted at 60% of his base salary. The Executive Chairman Agreement also provided for Mr. Berns to be granted an option to purchase 955,864 shares of our common stock, with an exercise price per share of $6.36, which our Board determined was equal to the fair market value of a share on the date of grant, that vests as to 25% of the shares underlying the option on July 3, 2024 and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date. Under the Executive Chairman Agreement, in the event of a change in control, as defined in the Executive Chairman Agreement, the vesting of each stock option and other equity award held by Mr. Berns will fully accelerate.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In September 2023, we entered into an Executive Employment Agreement with Mr. Lenz setting forth the terms and conditions of Mr. Lenz&#x2019;s employment with us as our Head of Research and Development. The Executive Employment Agreement provides for Mr. Lenz to be paid an annual base salary of $550,000 and an annual bonus targeted at 50% of Mr. Lenz&#x2019;s base salary. The Executive Employment Agreement also provided for Mr. Lenz to be paid a sign on bonus in the amount of $500,000 that must be repaid in full if Mr. Lenz&#x2019;s employment with us is terminated prior to September 2025 for any reason other than a termination by us for cause, by Mr. Lenz for good reason or as a result of death or disability, in each case, as defined in the Executive Employment Agreement.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mr. Lenz&#x2019;s Executive Employment Agreement also provided for a grant to Mr. Lenz of an option to purchase 502,934 shares of our common stock for $17.00 per share, the fair market value of a share of our common stock on the date of grant. Mr. Lenz&#x2019;s option vests as to 25% of the shares underlying the option on September 11, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date. The Executive Employment Agreement also provided for Mr. Lenz to be granted an award of 352,941 restricted stock units. Each restricted stock unit represents the right to be issued a share of our common stock following vesting. The restricted stock units vest in substantially equal installments on the first four anniversaries of September 11, 2023, subject to continued service to us through the vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Executive Employment Agreement, Mr. Lenz is eligible to receive severance in the event his employment with us is terminated by us without cause or by him for good reason, each as defined in the Executive Employment Agreement. In the event the qualifying termination occurs more than 3 months prior to or more than 12 months after a change in control, as defined in the Executive Employment Agreement, Mr. Lenz is entitled to receive 9 months continued base salary, his target bonus opportunity for the year of termination and up to 9 months of continued health-care coverage or COBRA reimbursements. In the event the qualifying termination occurs within the period beginning 3 months prior to and ending 12 months after a change in control, Mr. Lenz is entitled to his annual base salary and target bonus opportunity payable as a lump sum, continued healthcare coverage or COBRA reimbursements for up to 12 months, and full vesting acceleration of all equity awards. Mr. Lenz must provide a general release of claims in order to receive the foregoing severance benefits.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, we entered into an Executive Employment Agreement with Mr. Duncan setting forth the terms and conditions of Mr. Duncan&#x2019;s employment with us as our Chief Legal Officer. The Executive Employment Agreement provides for Mr. Duncan to be paid an annual base salary of $455,000 and an annual bonus targeted at 40% of Mr. Duncan&#x2019;s base salary. Mr. Duncan&#x2019;s Executive Employment Agreement also provided for a grant to Mr. Duncan of an option to purchase 400,000 shares of our common stock for $12.97 per share, the closing trading price of a share of our common stock on the date of grant. Mr. Duncan&#x2019;s option vests as to 25% of the shares underlying the option on December 11, 2024, and as to 1/48th of the original number of shares underlying the option each month thereafter, subject to continued service to us through the applicable vesting date.</font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Executive Employment Agreement, Mr. Duncan is eligible to receive severance in the event his employment with us is terminated by us without cause or by him for good reason, each as defined in the Executive Employment Agreement. In the event the qualifying termination occurs more than 3 months prior to or more than 12 months after a change in control, as defined in the Executive Employment Agreement, Mr. Duncan is entitled to receive 9 months continued base salary, his target bonus opportunity for the year of termination and up to 9 months of continued health-care coverage or COBRA reimbursements. In the event the qualifying termination occurs within the period beginning 3 months prior to and ending 12 months after a change in control, Mr. Duncan is entitled to his annual base salary and target bonus opportunity payable as a lump sum, continued healthcare coverage or COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">32</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reimbursements for up to 12 months, and full vesting acceleration of all equity awards. Mr. Duncan must provide a general release of claims in order to receive the foregoing severance benefits.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">33</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="security_ownership_certain_beneficial"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECUR</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents information as to the beneficial ownership of our common stock as of April 15, 2024, for:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock; </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each named executive officer as set forth in the summary compensation table above; </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">each of our directors; and </font></div></div><div style="margin-left:0.5in;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:4.1664861117129615%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">all executive officers and directors as a group. </font></div></div><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares beneficially owned, subject to community property laws where applicable. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days of April 15, 2024, and any restricted stock units that vest within 60 days of April 15, 2024, are deemed to be outstanding and to be beneficially owned by the person holding the stock options for the purpose of computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Percentage ownership of our common stock in the table is based on 159,452,584 shares of our common stock issued and outstanding on April 15, 2024. The table below does not reflect ownership of outstanding shares of our non-voting common stock. This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13D and Schedules 13G, if any, filed with the SEC. Unless otherwise indicated, the address of each of the individuals and entities named below is c/o Neumora Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, Massachusetts 02472.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:40.328%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:11.862%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:11.862%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:11.862%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:1%;"></td>
     <td style="width:12.081999999999999%;"></td>
     <td style="width:1%;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Beneficial Ownership</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of Beneficial Owner</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Outstanding Shares Beneficially Owned</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Shares Exercisable Within 60 Days</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Number of Shares Beneficially Owned</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Percentage of Beneficial Ownership</font></p></td>
     <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">5% and Greater Stockholders:</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amgen Inc. </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(1)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,368,653</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,368,653</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">22.2</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Entities Affiliated with ARCH Venture<br>&#160;&#160;&#160;Partners</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(2)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,932,138</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,932,138</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Named Executive Officers and Directors:</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(3)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">524,793</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">524,793</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Paul L. Berns</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(4)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,646,916</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">378,652</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,025,568</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Robert Lenz, M.D., Ph.D.</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Jason Duncan</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Kristina Burow</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(5)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,959,755</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,613</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31,971,368</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20.0</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Matthew Fust </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(6)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107,374</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Alaa Halawa </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(7)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,613</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Maykin Ho, Ph.D. </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(8)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">95,586</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">David Piacquad </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(9)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,613</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">*</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">All directors and executive officers as<br>&#160;&#160;&#160;a group (12 persons)</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;min-width:fit-content;">(10)</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40,774,806</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,785,567</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42,560,373</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="min-width:fit-content;">&#160;</font></p></td>
     <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26.4</font></p></td>
     <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;min-width:fit-content;">%</font></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;border-bottom:0.5pt solid;margin-right:5.5in;text-align:justify;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">* Indicates beneficial ownership of less than 1% of the total outstanding common stock.</font><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Based solely on the Schedule 13D filed with the SEC on September 27, 2023, by Amgen Inc. (&#x201c;Amgen&#x201d;), reflecting ownership information as of September 27, 2023. Consists of 35,368,653 shares of common stock. Investment and voting decisions for Amgen Inc. are made by an investment committee comprised of three or more individuals, and therefore no individual is the beneficial owner of the shares held by Amgen Inc. The address of Amgen Inc. is One Amgen Center Drive, Thousand Oaks, California 91320.</font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">34</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Based solely on the Schedule 13D/A filed with the SEC on December 15, 2023 jointly by (1) ARCH Venture Fund VII, L.P. (&#x201c;AVF VII&#x201d;), (2) ARCH Venture Partners VII, L.P. (&#x201c;AVP VII&#x201d;) which is the sole general partner of AVF VII, (3) ARCH Venture Partners VII, LLC (&#x201c;AVP VII LLC&#x201d;) which is the sole general partner of AVP VII, (4) ARCH Venture Fund VIII Overage, L.P. (&#x201c;AVF VIII Overage&#x201d;), (5) ARCH Venture Partners VIII, LLC (&#x201c;AVP VIII LLC&#x201d;) which is the sole general partner of AVF VIII Overage, (6) ARCH Venture Fund X, L.P. (&#x201c;AVF X&#x201d;), (7) ARCH Venture Partners X, L.P. (&#x201c;AVP X LP&#x201d;) which is the sole general partner of AVF X, (8) ARCH Venture Partners X, LLC (&#x201c;AVP X LLC&#x201d;) which is the sole general partner of AVP X LP and AVP X Overage LP (defined below), (9) ARCH Venture Fund X Overage, L.P. (&#x201c;AVF X Overage&#x201d;), (10) ARCH Venture Partners X Overage, L.P. (&#x201c;AVP X Overage LP&#x201d;), which is the sole general partner of AVF X Overage, (11) ARCH Venture Fund XII, L.P. (&#x201c;AVF XII&#x201d;), (12) ARCH Venture Partners XII, L.P. (&#x201c;AVP XII LP&#x201d;) which is the sole general partner of AVF XII, (13) ARCH Venture Partners XII, LLC (&#x201c;AVP XII LLC&#x201d;) which is the sole general partner of AVF XII, (13) Keith Crandell (&#x201c;Crandell&#x201d;), (14) Robert Nelsen (&#x201c;Nelsen&#x201d;), (15) Clinton Bybee (&#x201c;Bybee&#x201d;, and together with Nelsen and Crandell, referred to individually as a Managing Director or collectively as the &#x201c;AVP VII Managing Directors&#x201d;, &#x201c;AVP VIII Managing Directors&#x201d; or &#x201c;Managing Directors&#x201d;, (16) Kristina Burow (&#x201c;Burow&#x201d;), and (17) Steven Gillis (&#x201c;Gillis&#x201d;, and together with Nelsen, Crandell and Burow, referred to individually as &#x201c;Committee Member&#x201d; or collectively as either the &#x201c;AVP X Investment Committee Members&#x201d; or the &#x201c;AVP XII Investment Committee Members&#x201d;), reflecting ownership information as of December 15, 2023. Consists of (i) 1,387,228 shares of common stock directly held by AVF VII, (ii) 2,321,566 shares of common stock held directly by AVF VIII Overage, (iii) 12,205,379 shares of common stock held directly by AVF X, (iv) 11,886,758 shares of common stock held directly by AVF X Overage, and (iv) 4,131,207 shares of common stock held directly by AVF XII. AVP VII, as the sole general partner of AVF VII, may be deemed to beneficially own the AVF VII Record Shares.  AVP VII, as the sole general partner of AVF VII, may be deemed to beneficially own the shares held by AVF VII.  AVP VII LLC, as the sole general partner of AVP VII, may be deemed to beneficially own the shares held by AVF VII. AVP VIII LLC, as the sole general partner of AVF VIII Overage, may be deemed to beneficially own the shares held by AVF VIII Overage. AVP X LP, as the sole general partner of AVF X LP, may be deemed to beneficially own the shares held by AVF X.  AVP X LLC, as the sole general partner of AVP X LP, may be deemed to beneficially own the shares held by AVF X. AVP X Overage LP, as the sole general partner of AVF X Overage, may be deemed to beneficially own the shares held by AVF X Overage.  AVP X LLC, as the sole general partner of AVF X Overage LP, may be deemed to beneficially own the shares held by AVF X Overage. AVP XII LP, as the sole general partner of AVF XII LP, may be deemed to beneficially own the shares held by AVF XII.  AVP XII LLC, as the sole general partner of AVF XII LP, may be deemed to beneficially own the shares held by AVF XII Overage. By virtue of their relationship as affiliated entities who have overlapping general partners and managing directors, each of the Managing Directors and direct and indirect general partners of AVF VII and AVF VIII Overage may be deemed to share the power to direct the disposition and vote of the shares held by AVF VII and AVF VIII Overage. By virtue of their relationship as affiliated entities who have overlapping general partners and investment committee members, each of the Investment Committee Members and direct and indirect general partners of AVF X, AVF X Overage and AVF XII may be deemed to share the power to direct the shares held by AVF X Record Shares and AVF XII.  Ms. Burow has a pecuniary interest in AVP VII, AVP VIII LP and AVP VIII Overage LP, and while Ms. Burow does not have voting or dispositive power over the shares held by AVF VII or AVF VIII, these shares were included in the beneficial ownership reporting for Ms. Burow based on the Schedule 13D/A filing. Further, Mr. Berns does not have dispositive control over any of the shares held beneficially by AVF VII, AVF III Overage, AVF X, AVF X Overage, or AVF XII. The address of ARCH Venture Partners is 8755 West Higgins Road, Suite 1025. Chicago, IL 60631.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of (i) 382,345 shares of common stock held directly by Mr. Gosebruch, zero of which shares will be vested within 60 days of April 15, 2024 and 382,345 of which shares will continue to be subject to our repurchase right, (ii) 127,448 shares of common stock held by the Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust of which Mr. Gosebruch serves as trustee, and (iii) 15,000 shares of common stock held by the HG4KYC TRUST of which Mr. Gosebruch serves as trustee.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of (i) 7,646,916 shares of common stock held directly by Mr. Berns, 7,646,916 of which shares will be vested within 60 days of April 15, 2024, and zero of which shares will continue to be subject to our repurchase right, and (ii) 378,652 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of (i) 27,617 shares of common stock, 11,613 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024, and (iii) the shares discussed in footnote (2). Ms. Burow is an AVP XII Committee Member and an AVP X Committee Member and may be deemed to beneficially own the shares discussed in footnote (2). Ms. Burow disclaims beneficial ownership of the shares discussed in footnote (2) except to the extent of her pecuniary interest therein, if any.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of 107,374 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of 11,613 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of 95,586 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of 11,613 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:3.846%;display:inline-flex;justify-content:flex-start;">(10)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Consists of (i) 40,774,806 shares of common stock, 40,392,461 of which shares will be vested within 60 days of April 15, 2024, and 382,345 of which shares will continue to be subject to our repurchase right, and (ii) 1,785,567 shares issuable pursuant to stock options exercisable within 60 days of April 15, 2024.</font></div></div><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">35</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="additional_information"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ADDITIONAL INFORMATION</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Householding of Proxy Materials</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The SEC has adopted rules that permit companies and intermediaries (</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">e.g</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as &#x201c;householding,&#x201d; potentially means extra convenience for stockholders and cost savings for companies.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Brokers with account holders who are Neumora stockholders may be &#x201c;householding&#x201d; our proxy materials. A single proxy statement may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that it will be &#x201c;householding&#x201d; communications to your address, &#x201c;householding&#x201d; will continue until you are notified otherwise or until you notify your broker or the Company that you no longer wish to participate in &#x201c;householding.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If, at any time, you no longer wish to participate in &#x201c;householding&#x201d; and would prefer to receive a separate proxy statement and annual report, you may (1) notify your broker, (2) direct your written request to:490 Arsenal Way, Suite 200 Watertown, Massachusetts 02472. Stockholders who currently receive multiple copies of this Proxy Statement at their address and would like to request &#x201c;householding&#x201d; of their communications should contact their broker, or (3) request from the Company at (857) 760-0900. In addition, the Company will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of the Form 10-K, Proxy Statement, Proxy Card or Notice of Internet Availability of Proxy Materials to a stockholder at a shared address to which a single copy of the documents was delivered.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Matters</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of the date of this Proxy Statement, the Board does not intend to present any matters other than those described herein at the Annual Meeting and is unaware of any matters to be presented by other parties. If other matters are properly brought before the Annual Meeting for action by the stockholders, proxies will be voted in accordance with the recommendation of the Board or, in the absence of such a recommendation, in the discretion of the proxy holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="text-indent:36pt;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have filed our Annual Report on Form 10-K for the year ended December 31, 2023, with the SEC. It is available free of charge at the SEC&#x2019;s web site at www.sec.gov. Upon written request by a stockholder of Neumora, we will mail without charge a copy of our Annual Report on Form 10-K, including the financial statements and financial statement schedules, but excluding exhibits to the Annual Report on Form 10-K. Exhibits to the Annual Report on Form 10-K are available upon payment of a reasonable fee, which is limited to our expenses in furnishing the requested exhibit. All requests should be directed to the Secretary of the Company, 490 Arsenal Way, Suite 200, Watertown, Massachusetts 02472.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><p style="margin-left:252pt;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:46.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;"></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By Order of the Board of Directors</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ HENRY O. GOSEBRUCH</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Henry O. Gosebruch</font></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
    </tr>
   </table><p style="margin-left:252pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 25, 2024</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img218924107_1.jpg" alt="img218924107_1.jpg" style="width:624px;height:774px;">&#160;</p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">SCAN TO VIEW MATERIALS &amp; VOTE NEUMORA THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200 WATERTOWN, MA 02472 VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/NMRA2024 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. V50546-P05556 NEUMORA THERAPEUTICS, INC. The Board of Directors recommends you vote FOR the following: 1. To elect two Class I directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected; Nominees: For With hold 1a. Henry O. Gosebruch 1b. Kristina Burow The Board of Directors recommends you vote FOR the following proposal: For Against Abstain 2. To ratify the appointment, by the Audit Committee of the Company&#x2019;s Board of Directors, of Ernst &amp; Young LLP, as the independent registered public accounting firm and independent auditor of the Company for its year ending December 31, 2024. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date</font><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"><div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img218924107_2.jpg" alt="img218924107_2.jpg" style="width:624px;height:778px;">&#160;</p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ffffff;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and 10-K Wrap are available at www.proxyvote.com. V50547-P05556 NEUMORA THERAPEUTICS, INC. ANNUAL MEETING OF STOCKHOLDERS JUNE 13, 2024 8:30 AM EDT THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The stockholder(s) hereby appoint(s) Joshua Pinto and Henry O. Gosebruch, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of NEUMORA THERAPEUTICS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held virtually at 8:30 AM EDT, on Thursday, June 13, 2024, at www.virtualshareholdermeeting.com/NMRA2024, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations. Continued and to be signed on reverse side</font></p><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img218924107_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img218924107_0.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
M0@$J P$1  (1 0,1 ?_$ !X  0 # 0$!  ,!           ("0H'"P8! @0%
M_\0 21   00" @$# @(%!@83 0  ! (#!08!!P ("1$2$PH4%2$6(B,Q.1<X
M=WBVMR0R04)VD1@9&B8S-#4Z5UAA<WF6H;*SM-;7_\0 &P$!  ,! 0$!
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MB:.JN?'<N-&Q=AZD&8\0?3*H%'X>3G)WWSJ?=YG:M-?;C\QAVR.9$B4^@(K
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M:]^[6S;ILUISVY:LS47;)"2D9>OGV60Y>/T DYKY,B@3$^E4_GC]A_ZLY/\
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MV^ J)2H&$+XRM>#Q@.R^0#VDD*E1-=3=9;+TE7"3LLUSM@5=JJE!,5 Q&9
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MS9A*2)2?UTI+*?MP8*5;099-?M>@[;<4B9K8H^6JE]V9H6Q;G]M@[,S9M0*
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>:<::<::<::<::<::<::<::<::<::<::<::<::__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img218924107_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img218924107_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /= QT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 'I%%<?X5\0^))TOU\7:)%I1LXA+]HC?,3KR6QRPX Y^8URJ_$SQ9XGO;A?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%PDC #+&+]X&)''.>M7=/\3>%+"RBM[%XK*'[:MBMLEF\)2=\E5,>P%<\G)
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M=]JX]3U)KFM7\*^,O^$TO->L+$FY:[;8X: Q"#"I'(BLXS,J[L[QCT->QT4
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M]HNK3K/J.D6%Y,J[1)<6R2,!Z9(/')K2HH PO^$*\*_]"UH__@#%_P#$T?\
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M!=IPFWC.XG/\..:V=+\3SWVIQ6=Q8Q6P;SD,OGLRM+%(Z,B'RP#@(&Y*G#<
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M,#C&TDC%7+KQ+X:N-4C:\T"22]=3%)++:1.T4?FF"3<^X_*KG:P!/#9 (.:
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MMX1-"'D4%496VCY9<C#8^;GO0!/I]_:6_B4Z=!H=E;0P3/8P7$! <'RDG8;
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M/ID-S<1KX;TF:T@N'N;ET0MYV(9I$D3,2AG/E."W('0,<DKM17=K=:1!;_\
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M"%09 #?* II\FJ>'K";5(YO"D:&VE:*3R;>!C)#"D<AE(R/E7=&0.3]W SP
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MH/(BD5%^3^$@*2 ".@_04 :=%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY7]X^0<T 7U\8:&[(JW<FY@_R_9I<@IOW*1MX<>5)\IPQVG JGIOQ T+41
M;RWDG952.>U<')\L9. 0HW2JF6(!;."1@EMO\/\ 1;:=YHTP\D+0L5MX$(+*
M5+J5C!1L,?ND#J<9)R^U\$6%E:ND<US/(6BDW3.BEFCG:=<E4& 6(!P/NJH
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M%EN&D6,(J-RQC,@[=-@)ST[=>*K77CG0K6.U?[1)+]I,>T)$V55Y?*#-D#:
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M>2=T,JS$6;$P0J?+D'R >7R&V@@@Y&<@'<IXM\/23^2NL6?F;IE(,H&#%_K
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M1D90LA<!<F3!!'08R,FHM)\+74'AG1+:XNMFH6LWVRX=U\S?*ZN) <$?\]6
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M' .,G%=710!Q%Y\/C=:4FG#5 D)L(;.9OL^68P^9L93N^7F0Y'.0,9&3F1_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME,BECGB26)UDC=0R.AR&!Y!![BN+\'*NG6M_'/81:8M_?"*TACAD19&%LF2
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M#' &ERT+_.&B<@C!/F'YER0=;Q)X.OM9U&\FA:SVSQ.JSRLPD53;O%Y. O\
MJ]S"0\]1]T\$5H-(\10W>4AOXT:Y\R K>J$A4W<CR^:H?YRT+(!P^#G[IYI-
M,TWQ/IK:<\\6I7GDLK2QM?[PV8(=^6:8$MYBR;00R\M]T$, #5\1>#H]9N-/
M$5O8K:V<(A2)TP$7SH6(4 8 \N-UXQ]X#H37.7/PWUB6:8QZC&B9<6WERJHA
MBS(%AP86)C*L 1N !.=K;1GT^B@#S-OAQ?+%*MN+&)IH6#NTN6#E+I<96) 5
M_?QXP!@)@#@9;J/A.XTW5H([:Q@N+>6]MFM(HX9"+%%DA:1E(0HI;:Y;++D
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M[I);FYLH=+-Q<R7;7'G+D3++<1R(&RC E41@,JP5L<$9KO** /-X?AU?0Z7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$5&T0OY@0 EVV[\'"AY" FP&MOPW:7<?A^^AGFNQ?/=70:XEC592?,94<$J
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M&3C+8S7H5G>6]_ 9[:3S(A(\>[!'S(Q1NONIYZ'J.* )Z*** "BBB@ HHHH
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MHH **** *UUI]E>R0R7=G;W#P-OB:6)7,;>JDC@\#IZ59HHH **** "BBB@
MHHHH **** (GMH)9XIY((WFASY4C("R9&#@]1GOBI:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>X193:)EC;8TAYPP!PJG)!8@[]% !1110 4444 %%%% !1110 4444 %%%%
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MNC?^!\7_ ,56E+J>GV^FC49KZVCL2JN+EY5$15L;3N)Q@Y&#GG(JU10!A_\
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MZ!IUT]K>ZYIEM<)C?#/=QHZY&1D$Y'!!_&M6B@##_P"$T\*_]#+HW_@?%_\
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MGI^DP+/J-];6<+-L$EQ*L:EL$XRQ S@'CVJU10!A_P#":>%?^AET;_P/B_\
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MU_Y^8?\ OX* )Z*@^VVO_/S#_P!_!1]MM?\ GYA_[^"@">BH/MMK_P _,/\
MW\%'VVU_Y^8?^_@H GHJ#[;:_P#/S#_W\%'VVU_Y^8?^_@H GHJ#[;:_\_,/
M_?P4?;;7_GYA_P"_@H GHJ#[;:_\_,/_ '\%'VVU_P"?F'_OX* .)^+>DV%[
MX*GO;FUCEN;:2%89&'*!YHU;'U'%<OJ=A=Z1??$*Q\/V6G1:;'I4(N$ED=#&
MAAE)\L!2">7/)'.*]>^VVO\ S\P_]_!1]MM?^?F'_OX* /$)H+:>#5A=:E;V
M426^BN1=!S!<8@D/E2;.=IZ_4"NGUZZ6]^ -Q<)IW]G(]JNVVR<(!* ,9YP<
M9&>Q%>D?;;7_ )^8?^_@H^VVO_/S#_W\% 'B&K^$=2M-9TFW;2-.\N]N;J6U
MT5KEY((MMN,C> #EBNX  #('([.T.30);>U;QE=3W.G#2X5TR2XW[0X+B91M
M_P"6BMA1WP!7MOVVU_Y^8?\ OX*/MMK_ ,_,/_?P4 >*ZC_;DGAOPXMH+P^*
MTT^X:Y8'$JV!W "3/.\C9M[[L]ZT)]$TZXU+PY:>';C[/H'B>W$=Y @Y=;==
M_7LS %&_'OFO6OMMK_S\P_\ ?P4?;;7_ )^8?^_@H XWX@K'$-!CO5E3PV+D
MKJ2PA@H78?+#[>?+W8SVZ5PWBBYM=6EM;#P5:7%QINBPF^C?3EW)'=,^4W;B
M, !&/&3\W ->U_;;7_GYA_[^"C[;:_\ /S#_ -_!0!X=XUO(_$6O6>N0(JVY
MT.TN9+A6/FV:FZ(9XP.K+D@Y.,9IUTVF->>(VTXL?&)U]CIQM]WF%,Q_>QQY
M?W\YXZU[?]MM?^?F'_OX*/MMK_S\P_\ ?P4 <9XV ;Q?X34W#6X(U &91DQ_
MZ,WS#W'6JOPHEMQ8:E86T%K)':O&IU*UW^7>L5.6(?G>.-V.,FN]^VVO_/S#
M_P!_!1]MM?\ GYA_[^"@#Q=KU]"OI=#N8F-CX4N+G4TW?=D4@&U3Z[Y2/P'X
M8TMQ?:+X1\1Z+JEK?6TFIV4=^OVQ0I>X#H)MN"<@Y!YP>#D"OH'[;:_\_,/_
M '\%'VVU_P"?F'_OX* /*_'NM:;KLVGW>EWD5W;KI6LQF2,Y 86RDC]11X%_
MLW_A)=$_X1;?]F_LP_VUY6[R/-VKLSGCS-V[..<?C7JGVVU_Y^8?^_@H^VVO
M_/S#_P!_!0!Y%X@_LC^T/%7_  D?VG_A(?-;^Q=OF;_+\L>3Y&WC._.<=^M9
M&M_VU9W?BC59]\EQ'HUI9ZG O?S[9E9_JLBH?H6KW3[;:_\ /S#_ -_!1]MM
M?^?F'_OX* /(-!&BZG=Z]X<U2\C@GU*UTU;92?GWBT0AE]P<&NG^'=@^M>&[
MK6]:D6[OM75K:=MN (8RT00>QVLQ]2U=Q]MM?^?F'_OX*/MMK_S\P_\ ?P4
M?/E_J6H^'O$_VQO-:3PQ:II73[ZLDRQO^.8S^-=GI^F:OH7C#0M.T:"Q>\@\
M,[9EO9'1/]<I<@JI.=Q].YKU#[;:_P#/S#_W\%'VVU_Y^8?^_@H ^>M"?3TU
M#PN=1CTEHO[&3;_:,CJ%/VN7E-H.7] <#WJQK(O=.L/%,Z;Y=.U37Y;:5>T,
MT=RLB/\ 1EW@^X6O??MMK_S\P_\ ?P4?;;7_ )^8?^_@H&>:_%,6,.IV-]=S
MV5VT-LX31[T28GRP^:,ITDXP,@CZ=:Y_593+XQU5[Z&XM]"DN;-M2B!?Y/\
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M4 3T5!]MM?\ GYA_[^"C[;:_\_,/_?P4 3T5!]MM?^?F'_OX*/MMK_S\P_\
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M-'_"D?!O_/"\_P# DUZ-10(\Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J*
M/.?^%(^#?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX
M-_YX7G_@2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#
M?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@
M2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$
MFC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \
MY_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A2/@W
M_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4CX-_
MYX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A2/@W_GA>?^!)
MKT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4CX-_YX7G_@2:
M/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG
M_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^
M>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_G
MA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO
M1J* /.?^%(^#?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_
MX4CX-_YX7G_@2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^
M%(^#?^>%Y_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX
M7G_@2:]&HH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%
MY_X$FC_A2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&
MHH \Y_X4CX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A
M2/@W_GA>?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4
MCX-_YX7G_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FC_A2/@W_GA>
M?^!)KT:B@#SG_A2/@W_GA>?^!)H_X4CX-_YX7G_@2:]&HH \Y_X4CX-_YX7G
M_@2:/^%(^#?^>%Y_X$FO1J* /.?^%(^#?^>%Y_X$FHY_@;X0EA9(Q?PN1PZS
MY(/T((KTJB@#S#X9W^KZ9XDUSP5JUV]Y_9H62VG?[WEG&!SV(9"!VY'I7I]>
M9>'_ /DOWBS_ *\8?_0(:]-H *\R\0?\E^\)_P#7C-_Z!-7IM>9>(/\ DOWA
M/_KQF_\ 0)J /3:*** "BN<\5>(M1\/FP-II,-['=W,=J&>\,)621MJ\;&R/
M4_I573_&<9\4:CHFK-!:7$4D,<"H'92S0+(RF3&W.=V/NY Z4 =;167I'B+2
MM=:5=.N_.:-59@8V0E6SM8;@-RG!PPR#CK6!)X]\OQ\_A@Z<C;9XX!*ER#*=
M\/F[_*V_<'0MNXX]: .SHK$MO%VA7ANA;7PE-JI>0)$Y+*&*[DX_>#<",KD9
MXIG_  F>@;;$_;S_ *<TB0#R),EHV"N&&W*;21G=C R3P#0!O45R^B^+X-?\
M4W%CI[K+I\=A'<+*871F=G=3C=C*[0I! YSU-:%[XIT73M0^P75Z$N!L#*(W
M8(6^Z&8 A2W8$@GM0!L45SG@SQ#/XFT>;49D6,?:I8XXU@DCVHK%1DO]X\9)
M& ,XP"#5"Q\=2SZQ]ENM)\BR?4YM+ANTN ^Z:,MC<FT;0P4XP30!V5%<MI_C
M[1;FSLY+NY2VN+BS^VF,+(Z)%\WS%]@ 'R-UQS@8Y&;?_"9Z!]D%S]M;:9O(
M$7V>7SC)MW;?*V[_ +O/3IS0!O45S=MXYT6<:BTC7-NMC=BT8S6T@,DA ("#
M&6)R?E'S<9Q@@F9/&GA^26VB34-SW*N\8$,G 0X<M\OR;2#G=C'>@#>HJEI6
MKV6MV"WNGR/);N?E=HGCW>X# $CG@]#63_PG?AS[.TXOW,:RO%E;:4DLGW\
M+DA>Y' XSC- '1T5BCQ9H;27*KJ",MK%YTTJHQB1<!N9,;<X(.,YYZ57D\=>
M'(K=9WOW56D:/8;:7S RKO(*;=P^7GD<B@#HJ*YQ/'?AN2TENDU$M%$\4;$6
M\I),G^KPNW+!L'! (-/M/&WAV]MKBY@U)3#!"L[NT3H/+8D!AE1NR01QGGCK
MQ0!T%%<Y/X\\-VUO#/-J#(DOF[0;:7</+QYFY=N5VA@3N X.>E0ZOXRMK77-
M)TFPFAGN;J\CCN%*,P2)XW8$,/E#':N 2>"3CO0!U-%9^D:WI^NVSW.FSM/
MKE/,\IE5B.NTL!N'N,BJC^+M!C9Q)J*(8Y)XWWHPV-" 9,Y'  (Y/!R,9R*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#YLN>>G XJ*T^'6DV%K!'9W-W;7$%P;B*[@6&.1"4V$?+&%(*\<J3[UU]%
M',S>";":2ZD^VWR-/>)?J4=,PW"KM\Q,KU(&"#D>PJ33?!FG:7>&\@FNC<-!
M/#))(ZDR&602.[?+][<H]O:NBHH R/#GARS\,:=)963RO'),T[&7;]YL9P%
M51P.  *Q[WX<:)?Z596$[7#"REGEAE81NP,KEW!#(5(R?[N1@<UU]% '+1^
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M?%W_ &^?^E*5[?7B'PV_Y+KXN_[?/_2E* /;Z*** /,O#_\ R7[Q9_UXP_\
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M*(6VR,F9 6 .. -S9^53@XT-?\;:/X;OK>TOI#OE02DB2-0B%MH8AV4MSGA
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M"0!TS@<= * +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS,P+((6 (W<X;M6WX;T@Z#X;T[2C+YK6L"Q-(!@,0.2!Z9H U**** "BBB@
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MH **** "BBB@ HHHH \R\/\ _)?O%G_7C#_Z!#7IM>9>'_\ DOWBS_KQA_\
M0(:]-H *\R\0?\E^\)_]>,W_ *!-7IM>9>(/^2_>$_\ KQF_] FH ]-HHHH
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M* "BBB@ HHHH **** /,O#__ "7[Q9_UXP_^@0UZ;7F7A_\ Y+]XL_Z\8?\
MT"&O3: "O,O$'_)?O"?_ %XS?^@35Z;7F7B#_DOWA/\ Z\9O_0)J /3:***
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M)Y)YJ"TTOQ7I]EI]A%;W/E+%I\0:&Y15MTAF?S-X+\LT7EAMF0<$=  ?1:*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%82^,M ;[/MU ,9U9E B<E%5MK&0;?W8!!!+X (J!O'OAI;'[8=2/D^<L/\
MQ[R[MS(77Y-N[!520<8..#0!TE%<XGCOPW):2W2:B6BB>*-B+>4DF3_5X7;E
M@V#@@$&EM_'7ANZMI;B'4@T<:)(289 65SM7:"N7RP(PN>>.M '145SG_">>
M&O/@A_M,"28*R@P2?*&D,8WG;A/G4J=V,'KC(K/O/B%I</B"VMHKN$Z<L-T]
M[</%( ABV ;&P W)8'&[D <4 =G16:=>TU;6QN9)GCBOIE@MS)"Z%I&SA2"
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M<(7W+]H<-Y8V@!5P!A>,X]2:O44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !4 L;027+BU@#W6/M#",9EP-HW?WN..>U3T4 4K71]+L3#]DTVS
MM_)W>5Y4"IY>[&[;@<9P,XZX%6+FUM[V!H+J"*>%L%HY4#*<'(R#QP0#^%2T
M4 9&M^'-/UV"1+B)4F=50W"11M)M#;@N75AC/.".O/6DLO"VB6-M8PIIEK(;
M&-([>6:)7D0*<@AB,YR,_7FMBB@"A%H>D0*JQ:58QA3&5"6Z#!C)*$<?PDDC
MTSQ34T#1HX5ACTBP6))A.J+;(%60=' Q][WZUHT4 13VMO<F(W$$4IBD$L?F
M(&V..C#/0C)Y]ZJ76A:1?-*UWI5C<&5U>0RVZ/O95*J3D<D*2 >P.*T** *$
M>B:3%,)H]+LDE$7DAUMT#"/^YG'W?;I4,7AG0(75XM#TV-DX4I:1@KP1QQZ$
MC\36K10!1BT;2X2ABTVSC,;(Z;8%&UD78I''!"_*#V''2KU%% 'F7A__ )+]
MXL_Z\8?_ $"&O3:\R\/_ /)?O%G_ %XP_P#H$->FT %>9>(/^2_>$_\ KQF_
M] FKTVO,O$'_ "7[PG_UXS?^@34 >FT444 9>N:VF@VGVR>RNI[906FE@V8A
M48^9@S GKT4$\'BM2L3Q#HU]K!LUMKZV@@@E\Z2"XM6F29A@IG;(G"D;L<Y(
M'I6O&)@\IE=&4MF,*A4JN!P3DY.<G/'! QQD@$E9.NZY_8<5O*VFWEXDTJ0Y
MMC%\CNRH@.]U^\S <9QSG%:U9^L:6-7M(;<S&(1W4%QN"YSY4JR8ZC&=N,]L
MT /T_5[#5/,%G>6\TL.!-%%,DC0M_=?:3@\$?@:@A\2Z#<-"L&MZ;*T[F.$)
M=(QD<8RJX/)Y' ]15'0/#$NC36S3WR7"65F+&U6.#RB(@5/[P[CO;Y%Y 4=>
M.:SF\"W LM"LHM9=+33$MU>(1NHF:)U?=A9 N6V\[P^.HP>2 2WGQ$T5--DN
M["[L[G$\5NADO$C1G>5H^3RR@!6?=MP5Y&><=+'J-C+&9([RW>,0K<%EE4@1
M-G:^<_=.UL'H<'TKEK;P*\-U=2OJ:NDEW#/&JVVTHL=W)=;2=YW$F0KG X .
M*L^$=-718KHW;>1/?7CBWMYI$+Q1 %HX1M)!PH9L G )YXH DTWQSHFJ:I%:
M6]]:^7<6L-Q;2-.JM,7:13&$/.Y?+Y'7G&!BMNUU.POQ,;.^MK@0,4F,,JOY
M;#J&P>#[&N7L_ C6]K%#)J2.88+&WC=;;:0EM.95S\YR6!"D\#(SCM46F:-9
M>"[26TN-8*375J+>WNMDS-#%"K89R\CHH3?G("(">G(% &]_PEWAKR5E_P"$
MATGRF8JK_;8\$C&0#NZC(_,5;&M:4U_)8+J=D;R-=[VXG7S%7&<E<Y P0:X*
M+X?:Y:>+8M3AUF&<RV,MO/-<V\DZIRH&%DG9LL"W1MHV],'%7+?P#<3)J&FW
M-V8M)$I^S )NFD!L5M=Y?=C&"_RE<Y7.<'% '51>)='GQ)!J5G-;>7+(]S'=
M1&-!'MW9.[/\8.0"!W(R,PMXP\.K-;QG6[ BXBDECD%PA1ECQN.[..,G_OEO
M0UB7G@*XU.[OKV^U:(W=WILVG,8+0QQJCA=K!2YY&TYYYR!QMIFL>$HK_6+V
MV35U@N=3@O&\IK4OB&2.WB<@A@,AHT.3UWD8[T =+!XFT"Z+"WUO39=L;3'R
M[N-L(.K<'[HP<GI2_P#"1Z'LM7_MK3MEVQ6W;[4F)B#@A.?F.2!QWKG=5\$V
MWB&.Y>'5MJ2ZF]YN@7.UUA$!CRK \,F3@@\$<'FJZ>#+>1[[2SJH_M"33IUG
M*Q3/_P ?#(%ES+*YR/LY&-WOQW .NTK6M.UN&:73KN*X2&9X)-C9VNI((/Y9
M'J"".#5'2O%FEZC)<P/>V<%W!=2VS6S7*F3Y9C$I*\$;CMP,=6 YIVCZ9J&D
MWUQ!YUO+IDLMQ= ^65E6267?M^\00-S\X'5?0D\[JO@F\^QWI2Y%XHGNKRSM
MX(%BE6>8M@M*S[2J%\]!]T'G % '6:AKVE:5IYO[R^@CM1,(#+O!4/OV$$^S
M9SZ8.>AJEI?BW2M1AOF>]LX'LIITGC:Y4F-(Y&02-TVJ=H//'/4U5FTB%?#^
MG^&/MRQ:@42YCE:(N)'@ECD=R 1D%RN1D$[CCVIWG@#[9 JG4O+D$MS/O2)E
MR\MS'<#[KA@%,07A@2#P5(% '70WEK<6:WD-S#):LN]9D<%"OJ&'&/>LS2?%
M.EZOI2:@DWV6-EE<QW9$4B+&<.S*3P!E23V##/6J\?AI3X1?0OM0"3,PN)8_
M,/F!Y"TH^>1F!8%P26)!8GVK'U#X=>9->MI>JO:QWEK+;2)=+)=D"5 DC!FD
M#;BL<.,D@;.AS@ &QJ_C'3-*U"WLA<6UQ<NTGG0I=1K)"JPO+N(8@ '8!EBH
M^8'-7+7Q)I%[IM[J%O?PR6MDTJW,BG/E^7G=G'L,CU&".M<?JOA&"^U%]%;Q
M!;P!C<7$=N]GF;=<Q3(?WA<!@,2L% SA,'@ UU%MX=C;1=5TNXN1/8ZC)<./
M+3:R).S,PW9(8@N<' XQP>M %B#7$-G->:C9SZ1:Q!3YVH21(K ]_E<[>W#;
M3R/?!+XG\/PF,2ZYID9EB\Z/?=QC?'S\PYY7@\].#5.?1-7O+:$7>K6DES:3
MI/:RK8LJA@K*?-7S3OR&/0I@\CMC&M_"UK;ZHUC)JADOYWMKYU2T8*OE7<MP
MQR"0@9I&4 G("_Q<T =++XH\/P",S:[ID8DC$R;[N,;D/1AD\KQUZ57OO&&A
M:9?06U[J5M!]HC62&1YX]KJ5=L_>R!A/O$ $LH!)R!B67A2SLO$UL3JHDN/.
M>^2#R."J27&1NS@8-ZH_X!TYXEL_ ;V-SI,\6J!FL(;: A[?(D2*.>-OX^"P
MG..NTJ.&S0!NV'B;1-22R-KJMHSWL7G6\1F42.O.<)G/&"#QP00>E6[/5=.U
M&WDN+&_M;J&,E7D@F5U4@9()!P.*\\M?!&FS7::/+XHM;JXBMHHKBUBDDCE'
ME((T=8UGVJ0NTG<C\Y/ .!T6F^"5M="U73;J],S:C;_9GG0S;@FPJ/\ 6RR<
MC<>F![4 6KOQCI2SZ1%87VG7IU&\^RJRWB[5PI9B"-V2/E 7NSJ,C-&L>,])
MTFYGM&NH'NK:2V%S&TP3R8YI F\D]E#!C[%<XW U';^%;C^V[;5[[48IKN&9
M7806QBC95AEC4!2[8/[XDMDYP!@8J34O#$FH:W)?"^6.*3[$7B,.YMUM.95(
M;<, ABI&#V.>Q -0:UI3/:(-3LR]XNZV43KF<>J<_,/I4-_K7V2_%C;:=>:A
M=",2R1VWECRT)(4L9'4<E6P 2?E/'%<_'X 6/58+S^T#(BR^9)"XE56Q<R7"
M8"2JN5,F/G#CY00!SG2GBDG\3W<NC:C%!?)!%#>I<63S1%06:/#!D ?]XW&X
M\,,CH: -&7Q!HL$]Q#-J]A'+;8,Z/<H&BR0!N!/RY+ <^H]:B3Q1X?DCDD37
M=,9(D#R,MW&0BD@ DYX!) SZD5@WO@-[YXHYM3C^Q6VH'4((Q;?/O:;S75WW
MX=3E@!M&,J3G;S2U;P<^HZ7%<:/J$%S(UU)<(PC5D99[R"X+'YL,%2/IGYAC
M&.!0!V">(-%E^R^7J]@_VLE;;;<H?.(."$Y^;!XXI;/7='U$@66JV-R6<1@0
M7"/EMI;;P>NU6./0$]JYF7P+?W%ZES-KWW[Q+VYAB@DCB=U=&&Q!+@9$:@[_
M #.<L,$U5U'P)<P:)#:6%S++="UL[%)XU6,P>4\A:<[F[K*X( )Y[YR #J[/
MQ'I5]>FTBO(1,QS K2*#<IL#>9$,Y=.2-P&,JW89JNGBFT;7IM*:VN8S'*T'
MVE]GE-(L2RE1\VX81@<E0.O-!\/-'X@L-0M+B.UMK6 0-!'&VZ9 &"HS;]I5
M2P(!0D$'# $BL?4/A['J6M:E>RWD,:7WF;C%:[;@![?R"AEW8:,??V[?O8Y]
M0#?_ .$H\/\ V>.X_MW3/(D<QI)]KCVLXQE0<X)Y''O576?&6B:1IFHW/]IZ
M?-<6229MA=HKM(JDB+J2&)4C&,^U<UK_ (7FN[QH-0\50VMWJ5LT+I%;RP0R
M(I6-2%68?.&F P[,&W@;3@5I7G@2673[BWM-3CAEN4OXI9);4R QW4@=L .O
MSKM4!LD<<CI@ Z:[U;3].@AFU"^M;-)2%0W$RQAFQG )(R:I:5XA@U74M:MH
M3 T>F3+ S1SAW9M@9LKCY0"2HY.2K=,52\36L%N;/49=;L-+,4,MEYE^@:)U
MEVD@ NN'_=#')XSD'M9\-:-::;IEPMA?"[M+MDDBE#!_E6&.(?,"=W^JSGWH
M AT_QE:WT%M*]A>V@NXHY[87)A7SHG=%W@B0@8,J94D-\P !) K1M_$FA74D
M4=OK6G3/,Q2)8[I&+L.2% /)&1T]:Y^#P-<'3].MK[5HYFTV&"WM6BM/+"QQ
MRPR'<"[%F;R$&00!SQ567X9036EE:/J#&WBL8+*= )4\P1,S*ZA)54-N8GYP
MX! ('7(!T<?B[P]/?PV4&LV,T\PD*"*=6&4V[@2#@'# XZX!]#4J>)_#\B0N
MFN:8R3.8XF6[C(D88RJ\\D9' ]16!_PCTOB+38C)K-O+%';WFEL]O8M%F)]L
M;@ N<.KP_>^Z1D;>]3Q>#)I->?6M0OK2ZO'LI;,QK9%("K;<$H9">,,#S\P;
M' % '26.H66IVPN=/O+>[@)*B6WE61<CJ,@XK'UKQEH^DV%U-'J&GSW%O(D+
M0&\1=KNX4!SR4 Y).. I..*J^%I38RWVGOK^FZA;6:[F$4A+V[;F#(P:1RB*
M%&-Q)R6Z  54@\%_:K:P9=8AFLK6.,6#0P<F+SX9\N^\B0GR5 8!>I."30!O
MWVN_8KRPLTT^YO;F\B>55M&CVJJ% Q+2.F1F1<8Y/I2R>*?#T-R]O+KVEI.C
MF-XFO(PRL#@J1G(.>,5BZW;:3XBO;75K?5]"ECT=95G^UQ)=11%BAW'$B^6R
M^7P3ZFJ,^A:)=#[&OB.P$VI6^H_9U!0M*+QPP=!NRVT*1D?>'I0!TNH>+?#^
MENT=WK%C'*DR0O'YZ[T9S@!ESD>IST )Z"G:OXBM-&O]/LYXIY)+Y]D9C"X7
MYT3)RP)^:1.%!.,G& 36'-X6EN-0OHH-<M89#+;W:VD<#%4=)A(LDB&7DMY9
M!*[,\DY(XN>(_"DVN:A#>0:BEI+'%Y:NT!D>'YL[XF#KL8]"2&!  (QG(!K:
MIK=GHTMN+]FA@F$G^D-CRT*KNVL<Y!*AB./X3WQF&V\3:3/&/-O;>UN!!]HD
MM;F9$FACQG+KN^7@@G/2H[OPZEYX9L]&DDC"VYMB6$7RMY+HV I)P#LQR3@'
MOWRM2\#/J27-K)J2I82RW,Z(+?,JRSQR1L3)NPRCS6(7:#PHS@4 =!=:]H]C
M(([O5K&WD+F/;+<(AW *2N">N'0X_P!H>HIPUK2CJG]EC4[,ZA_SZ>>OF]-W
MW,YZ<].E<S)X%N+LZE+?:M%)<7T-W&S16A14,\4,>0I=ONB'UYW=N\5IX?U6
M/QA:,L;)I-E>7%[YDT4>Z1Y8W4A765F(S(2 R+@#&3@4 =%+XCLXOM6Z.?\
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M''(PN)+A=JK, ,-(<;_,'RC@<Y .F3Q+H,EE+>IK>FM:1,$DG6[C*(QZ MG
M)J5-<TF2\DLTU2R:ZC3S'A6X0NJ8!W%<Y P0<^XKC+#P#J,^AZ6U]J2V^I6M
MM:1(L*2(L0BCE3:QCF#,W[]\LKJ#@<8R#=;X=V[Z:U@+WRH&=SMBB(VHUD+7
M8"S$X& W)/0 YZT :MCXQT:]EO/^)A8QV\-VMK!<?:T*7+&)'^4]"<N5P"?N
M_A4UWXN\/644\DVLV.+>5(9@DZL8G9MH# '*\YSGH 3V-<_>_#ZYU.[N+R]U
M:"2XN7D\Y8[>:&)XWCAC9-J3ACQ O5BIW'*],6;CP*TD<?E:D$DB>>1&:WW
ML]XETN1N&0I3;C(R&)R* .ENM6TVQ>W2[U"TMVN3B!99E0RGC[N3\W4=/457
M?Q-H$=E'>OK>FK:2L4CG:[C".PZ@-G!(JKKOAF/7Y$:YN-@%A=63;$Y_?A 7
M!)XQL/'.=WY\KK'@W5;72YH=-S>7][!=6T\P5FCVS)$N7,]R7! A0!E+X /R
M'B@#K;GQ=H=C;337FHVMNT0F;R6N(VD=8V96*JK$G[IXZ]B <@61XBT1L8UB
MPY@^TX^TIGRL9\SK]WWZ5S4OP_DD^TQIJJQ07,=W'/Y<#"259VF8*Q\S:50S
M9&4SE3@@,13+[X>RZC-?2W.J1LUY$P?$4P$<K6_D;T3SMGW>S*S<D;L8P =/
M%XCT.<R"'6M.D,<7GN$ND.V/&=YP>%P1STYJ#2O$VGZK!JEW'<6PL;"X,)NU
MG5HG41)(7W= !O(Z_P /6L&\^':W6H75Q_:)V23M=0*XF8PS%@V=OG"-ER,%
M?+!(XSWJQ=^&=0C\(>*+07$-[J&K>=*!#"($WM"L84 NV/N#DGO0!T$.NZ1<
M6_VB#5;&6#8\GFI<(R[4QO;(.,+D9/;(S6*?'.G_ -C:S=QO;27FF?:B]BMT
MID9879=Q'50VT'IQN'6JFH^!KW4([V9M8@2_ODGBN)19,8O+EBBB8)'YN5($
M*')8\YXP<".X^'TUU:W=G+J\?V65[R6$)9[9$>X#@[FW_.H#G P,X'/ H ZB
MWUW3;BYCM?MMM'=RM(L=LUQ&9'",RDJJL<CY&/J,'(!! T:YG0/"UQX>U"[E
MM]1BDMKVYEN;F*2V.\LS,P".'^4#<O!5LX)&-U=-0 5EZAXAT[3;Q;.=[B2Y
M:/S?)MK26X8)G&XB-6*C/&3C.#6I7*6/R_%'60>"VEVI7/<!Y<XH W-,UJQU
M<3_8Y)"\#!)8IH7ADC)&1E' 89!R#CFK]<MHG/Q \5D<@1V2DCUV.<?J/SKJ
M: "FNZQHSNP5%!+,QP /4TZLSQ(I;PMJZJ"6-E, !U/R&@"A_P )OH0M1=-)
M?+:$!A<MIMRL.T]&\PQ[=O\ M9Q[UT0((!!R#WKB=4D3_A2D[[UVG0L!L\',
M.!^M=9IBE=*LU8$,($!!ZCY10!:HHHH S]3UNPTAX([N24RS[O*B@MY)I'V\
MDA(U+8&1DXP,BF:=K^GZI=2VMN\Z7,2"1H;FUE@?:20&"R*I(R",BL?4/E^)
M^AD\!M.NU!/<[HCC\J<W/Q5CQSMT1]V.V9UQG\C^5 '4T444 >9>'_\ DOWB
MS_KQA_\ 0(:]-KS+P_\ \E^\6?\ 7C#_ .@0UZ;0 5YEX@_Y+]X3_P"O&;_T
M":O3:\R\0?\ )?O"?_7C-_Z!-0!Z;1110 4444 %<IX[MM>N]+CAT&&9ISO/
MF07!C:-MOR=)8P1D\Y+ 8'R-VZNB@#@I].UXW#-/9ZU.?MTCW+6VIB-)[8F3
MRTA'G+Y;+F+=PF=C?,<_-!?:1XIF6Z2R&IP73+<;;A]1_<^487$,83S#B57,
M67V]58[SGGT2B@#SN^TOQ7JLVHW*IJ=D"EY)9P?V@$*R>3;B 'RY"N-ZRG!.
M 2<\'F+4O#_B6.77#I$=]%+=WDEPLRW^%D5K%D4 &3*D38[#'R8X4;?2:* /
M*_%G]I:%9WL,M]?"V(NUTN--6*7#R&*$Q-EI0\H5_.&S+'YE^5N,=!XMT#5-
M0NH;W3?M(NX=)O(8WBNVBVSMY?E\;@.</STX&>BX[2B@#SC4?#/B:;[9<6]Y
MJHN'&I21JFJ.J!S*OV0!=^T+LW<8QV;TK>%AK%EH>NVENEQ<G[01IZS7CM(8
MC''G]X9 ^0QEQEU/ &0,&NIHH \XTW1/%N(KBZEOUF@-OY,9OR%*_;9&DWKY
MKACY!4?,S\<9)%7?#6CZS!XK@OM2MK[='I\\%Q=7%Z)8IIFEC;,2;R8U(0G&
M%QP,<<]U10!P%MHWBE=2DO)9KW='=Q&!3?$QF(WDYEW)OVM^X:/&1D8 '(Q6
M3_PC_BP$S1V^HI.8+2*]D>]\Q[IT$YD,1%PC*F]XV"[X^,_+U4^JT4 >86=K
MXHN;G4H;.YU)M0MF,+7EQ<@0?\>"83R1(RA_/=7)"D#GYCT,B:#XL>SD?S]4
M66*VNI+6-[LQ[;C]SY*M_I$OF*2LI^=R/F(P!BO2Z* /--3T+Q1-JD]S:PWP
MNE6Z4W;7@,<D;W,+(D*><"A\E&4X\OD#YLX:K5MH?B@-!<27.HM) EKY:O=&
M,?\ 'V[3*Z"9P^("JY9F)&.2W3T&B@#B;+2-5TOP1J.GVEE=->&_G,:O>LS2
M1O.6#HXE5A^[.<%T)8'."Q)S].LO&MO%:PW4=Y(TDEKOE%VI6!([N1GW REC
MNA,8."Q(!!)(Y]&HH \STWP[XB;5[>2YAU&%7A@@U&>74=QG98KH2,A60LL>
M^2(JHVX/(48I=%T/Q+9:=I5LUKJ<,T"6B(W]H+Y,$:;1.DB"4ARV)-I"M@.@
M^3;QZ710!R":5K%MX*TBU)U">[00OJ4:WS?:)?D_>*DK.-IWX/# 8! (S4?A
M70-2L]?N=3U(70,EFD47G7C2E0)YRJ.-Y#,L;1 GGG<022Q/9T4 >81^$=:M
MH9#9V]]#<VD>IFUD.H']Y+)<1R0'/F$E&5>5?@D$L,G)W?!^G^)+35;N76[B
MX960@AOFBD??D,A,[E0!D8$<8P1QQ7944 <7:VFN67A>30[?3KB.ZA4YOXYH
M@ER/,!<J=^]9'4MR5 #'.>,UEW.@^)[F*\:V.KVL26]T^GP2ZJ3+'-M@\H2,
M)"'RRSD!F8 , << >D44 >8:I8Z]!KLNE6CZO*K07DFF%-2;]V=ML$EE9I 7
M19&E^5MQP?ND58N-*\7WGB&[REW;Z;-.@?RKYURBW49W(?/)7,(D)"K'C.,'
M@UZ/10!P%M'KD.O:1I,E_,?,,KW4;7)>2.W@G=H'ZDGS R(Q)RP&#G! +OP[
MJ=OXAU6^CM]4N+"[NS(T%EJ1ADD_<1!7!,J@*'$H(R#]W@JH%=_10!ROAC2=
M:M7OKK6KJXFO'B@BC_TEC%Q;Q!V5,[03*'YP#] :Y:W\.>);+2KAOL^K2ZG*
M]I.S1ZE\D[+:JCI(WGHP_>*V67/\&-X&T>IT4 <7XG.L3^);33M&U#RI;JU:
M69/-/[CR26C?:/X7=@C=,@8YQBN:ET?QT-*DAB74GF96*%KDJT4H4 $'[:=R
ML3GYB0I7_5G<:]9HH XX:1K\7AC6_)N;G^V+NZF>+S;IG"Q><VQ8QO 3,?3!
M7DC)&.,@:%XL?3PWVG4O.AM;N2VC:Z,16XW1&%7Q<2>8.)?ONPPV#CBO2**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,O#__ "7[Q9_UXP_^
M@0UZ;7F7A_\ Y+]XL_Z\8?\ T"&O3: "O,O$'_)?O"?_ %XS?^@35Z;7F7B#
M_DOWA/\ Z\9O_0)J /3:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \R\/_ /)?O%G_ %XP_P#H$->F
MUYEX?_Y+]XL_Z\8?_0(:]-H *\R\0?\ )?O"?_7C-_Z!-7IM>9>(/^2_>$_^
MO&;_ - FH ]-HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#S+P__P E^\6?]>,/_H$->FUYEX?_ .2_
M>+/^O&'_ - AKTV@ KS+Q!_R7[PG_P!>,W_H$U>FUYEX@_Y+]X3_ .O&;_T"
M:@#TVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /,O#_P#R7[Q9_P!>,/\ Z!#7IM>9>'_^2_>+/^O&
M'_T"&O3: "O,O$'_ "7[PG_UXS?^@35Z;7F7B#_DOWA/_KQF_P#0)J /3:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH \R\/_\ )?O%G_7C#_Z!#7IM>9>'_P#DOWBS_KQA_P#0(:]-
MH *\R\0?\E^\)_\ 7C-_Z!-7IM>9>(/^2_>$_P#KQF_] FH ]-HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#S+P_\ \E^\6?\ 7C#_ .@0UZ;7F7A__DOWBS_KQA_] AKTV@ KS+Q!
M_P E^\)_]>,W_H$U>FUYEX@_Y+]X3_Z\9O\ T":@#TVBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,
MO#__ "7[Q9_UXP_^@0UZ;7F7A_\ Y+]XL_Z\8?\ T"&O3: "O,O$'_)?O"?_
M %XS?^@35Z;7F7B#_DOWA/\ Z\9O_0)J /3:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \R\/_ /)?
MO%G_ %XP_P#H$->FUYEX?_Y+]XL_Z\8?_0(:]-H *\R\0?\ )?O"?_7C-_Z!
M-7IM>9>(/^2_>$_^O&;_ - FH ]-HHHH **** "BBB@ HHHH **** "BBB@
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M=V5^5@S&MC3[_P ,ZUJ?]EVVEQRK'91R([V!$8C)EC\OE?EV_O%VG'WG'4,
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ML=LXYZUR/B:;PY#+;0I#:6N93IMU=PVBB>WB^RM*L<9*GJNQ< 'AR!@XQ?\
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MS0PO%&9',0X"2AU4+$. ^23G/8@$AT7PLT9LI/$09&L'6RA-Y"#:VS$.7AP
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M&;.U 0H/F2R=,G[NT>U=!0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'F7A_\ Y+]XL_Z\8?\ T"&O3:\R\/\ _)?O
M%G_7C#_Z!#7IM !7F7B#_DOWA/\ Z\9O_0)J]-KS+Q!_R7[PG_UXS?\ H$U
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MZ%K1O_ "+_XFC_A"_"O_ $+6C?\ @!%_\30!N45A_P#"%^%?^A:T;_P B_\
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M"_"O_0M:-_X 1?\ Q-'_  A?A7_H6M&_\ (O_B: -RBL/_A"_"O_ $+6C?\
M@!%_\31_PA?A7_H6M&_\ (O_ (F@#<HK#_X0OPK_ -"UHW_@!%_\31_PA?A7
M_H6M&_\  "+_ .)H W**P_\ A"_"O_0M:-_X 1?_ !-'_"%^%?\ H6M&_P#
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MKTVO,O$'_)?O"?\ UXS?^@34 >FT444 8=K_ ,CUJW_8,LO_ $;=5N5AVO\
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M@N,&17 WA66++8 ._% ';?:O%7_0&T;_ ,&TO_R-1]J\5?\ 0&T;_P &TO\
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MWSB4?=&U@=IVEL_.>" -H!L?:O%7_0&T;_P;2_\ R-1]J\5?] ;1O_!M+_\
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MU'VKQ5_T!M&_\&TO_P C5N44 8?VKQ5_T!M&_P#!M+_\C4?:O%7_ $!M&_\
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M1_:WQ@_Z%[0/^_A_^.UZ;10!YE_:WQ@_Z%[0/^_A_P#CM']K?&#_ *%[0/\
MOX?_ ([7IM% 'F7]K?&#_H7M _[^'_X[1_:WQ@_Z%[0/^_A_^.UZ;10!YE_:
MWQ@_Z%[0/^_A_P#CM']K?&#_ *%[0/\ OX?_ ([7IM% 'F7]K?&#_H7M _[^
M'_X[1_:WQ@_Z%[0/^_A_^.UZ;10!YE_:WQ@_Z%[0/^_A_P#CM']K?&#_ *%[
M0/\ OX?_ ([7IM% 'F7]K?&#_H7M _[^'_X[1_:WQ@_Z%[0/^_A_^.UZ;10!
MYE_:WQ@_Z%[0/^_A_P#CM']K?&#_ *%[0/\ OX?_ ([7IM% 'F7]K?&#_H7M
M _[^'_X[1_:WQ@_Z%[0/^_A_^.UZ;10!YE_:WQ@_Z%[0/^_A_P#CM']K?&#_
M *%[0/\ OX?_ ([7IM% 'F7]K?&#_H7M _[^'_X[1_:WQ@_Z%[0/^_A_^.UZ
M;10!YE_:WQ@_Z%[0/^_A_P#CM']K?&#_ *%[0/\ OX?_ ([7IM% 'EEW=?%?
M4+5[6]\*^&KFWDQOBF^=&P<C(,N#R!2VU[\6;.WCM[7POX<@@C&U(HCM51Z
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-)))X[<<5VM%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img218924107_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img218924107_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /H R(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTC<#Z_3&>.X]BZC!JE#H^F6QB,&G6D1B1HX_+@5=BL<LHP. 3R1WI=_ZZ/\
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MR1)9K%;K&F<(L62 ,DDY)I+S#^OR.FCSY:Y?><#YO7WIU( %4*H  & !VI:
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M6MIKU[5KY+1PZP"WR>& _P"6I8'G/3\*Z.RTS3]-#BQL;:U\S!?R(E3=CIG
MYIITG33>&\.GVANB03-Y*[R1C!W8SV'Y"CJA=&<I!JVKVNF:3J4M])>/>B4/
M;-%&J B*1UV[5#9S&!R2#D\#C$UF;@^)= EGU8WIN+&>;:R(NW(CY3:!\O/?
M)Z<UU2V=JBPJMM"JP',(" ",X(ROIP2./4U#;:1IEG<&XM=.M()CG,D4"JQS
MUY SS1U_KS&_(Y_5(+Z\\3ZI9V<-JXN-+ABD:XD90@+S#(4*=W4\9'UJ!;O5
M;2"^8ZK)Y<5_%I\0,4>V%#Y8,A.W);YCC)QSR#78B&(3M.(D$S*$:3:-Q49(
M!/H,G\S3&L[9HIHFMX3'.294*#$A(P=P[\#O0M/Z\_\ A_O"6K_KM;_(Y6_U
M74M+&I0QWKWDED8)(?,C3=<,Y8&W.U0,G P0 1N&<C.8)/$.HVEC:S->K</J
M=J5MCY:JL=V7P$ P#_'C!YQ$<\YKK(-*TZUCCCM["UA2-S)&L<*J$8C!8 #@
MX)&?>JMQHD<^HV4P\B.VM96N1"D."TQ##>6SCHQ.,9SSFFOZ_K^OS#^OZ_K]
M!VJ:;+?6ELL=T([NVD6:&5TW*7 (^91C(()X&/48Q6$UU<:KJ^A3//):R175
MQ!-%"4>-G1&!(++D@XQV_ BNHO+&SU"$0WMK!<Q!@P2:,.H([X/>F-I>GM;P
M6[6-J8+=@T,9A7;&1T*C& 1[4A-:',+J]Y<ZO!%#=ZA]COQ.L<DJ6X4!5)#1
M #?QC'S@]?I5'2+S5$T?0].M9[]RVE)<"2$6^]C@#:?,P-J^PSR,GU[2'2=-
MMKEKF#3[2*=F+-*D*JQ)SDD@9SR?S-1R:!HTML+:32;!X Q<1-;(5#'J<8QD
M^M"VM_77_,HYB_U+7EMM4N6O?LDUA803_9DCC=#*58N&)!)7*XX(/7FI+_5M
M5TR]GTX7=Q=EC:[9]D*R1^:TBL%R%3_EF -V>6[]*ZMK&T9)4:U@*RH$D4QC
M#J. #Z@9/%$UC9W E$]K!*)D$<N^,-O49PK9Z@9/!]33;)6VIS0N->:YT^QG
MNKBT$]U*GFND#3/$(MPSM!0'=D<#H.G-5XGO;S5M%\_4IRUO?74!94C'FA%?
M!8;>I P<8'H!75V^F6%FD:6UC;0+$S-&L42J$9NI&!P3DYHDTVPF55ELK9U6
M7SE#1*0)/[XX^]SUZT=0MH9^O7DD<EM:6TU\EU*'D"62PEBBX#$F;Y0 67W_
M %K TW5=7UJ%YAJCVHCTJ"Z ABB.Z1C+DG<K<'8.!^!KL+S3K+4%1;VSM[D(
M=R":)7VGU&1Q3H[&TAW>5:P)N01MMC RHSA3[#)X]S4]&4FCB]2U*^U70-7N
M&U'[#'!IB2^2J(5??$6)8L"V,Y48(Z'K76QVL-[HD5M<)YD,D"JZ$D!A@<'V
MHN-&TN[\K[1IMG-Y*;(_,@5MB^@R.![5=5550J@!0,  < 4W9WMU)5[+R_X!
MQEB OA[PBK "V%R@D!''^KDV?^/[,>^*O65[-::OK M-,N[V%[U03;M$%C;R
MH]Q.]U[_ -W/(-;S6-H]D;)[6!K4KM,!C!3'IMZ8I]M:V]G L%K!%!"OW8XD
M"J/H!Q3O_7W?Y#?]?C_F<38D1>+;Z35!G3_[186;#_5QW&Q!^\]R.%/3.1U(
MST^N7AMK2*..6Z2XN)1'"+18S([8+$#S/D'"GD]AZU=>QM)89H9+6!XIR3*C
M1@K(3W8=^@Z^E%U8VE[;_9[NU@N(<@^7+&'7(Z<'BET2[6!;M^IQ^EZKJVIZ
MC8VIU">%$^V>=B.$R2^3*BJ&(!4'#$';[XQQBYX;U'6=2>SO9H[G[+=1LTRS
M>0(XCU CV'?P>#NS^'2NC@T^RM2AM[2WB**50QQA=H."0,#@' S]!3(=*TZW
MO7O(+"UBNI,[YTA57;/7+ 9/0?E3!G/>)=:NK&:XEL9KT_8UC,R(L'D L1@.
M7^<D@_P=/K1_;EU%K$FES7.U[:>6YGD*#/V0)N7@#^\X7/4[#WKH+C2=-N[D
M7%SI]I-.%VB62%68#GC)&<<G\ZF^RV_VE[CR(O/=!&TNP;F49(4GJ1R>/>ET
M#J<2^NZG#))"9KTK)!%/&U[';[@#.B941_PE6_B&1CUS5F&\DCBFM+::^2ZE
MU"[D"62PEBBOAB3-\H ++[_K72PZ)I-LI6#3+*)3U"6Z*#R#V'J ?P%.GTG3
M;I EQI]I,H<R 20JP#GJW(ZGUH_K\0_K\+'%:1>7FKZE)>_VL;*9]%MIW,:1
MG>0TW)W!AM]<>O6G)K5]NEO$BDCN;Z/3UD\H)NC+JY.W>0N<\#=QDCKTKL)=
M#TB<H9M+L9"@ 0O;H=H&< 9'&,G\S4\MC:3K,LUK!(LZA90\8(D Z!L]1R>M
M-L'J[_UM8I:/+?K97!U195\N0^6\_E^8T> <L(_ESG<..P%<I=:K?7<%Y:B[
MU$6UWI-Q=127"6X;"E<% @)"D/CYQGIT.:[FTLK2P@\BSM8;>')/EPQA%R>I
MP..:AMM'TRS9FM=.M(&8$,8H%4D'&0<#O@?E2>O]>0XNS*4BWUOX0S97#R7L
M=J'C=U4ER!G:0 !STZ?K7/2>++V2YFNK6=&L=0B,&EC8,"X&T9SU.2[<>D9]
MZ[6UM+:RMDM[2WBMX$^[%$@15^@' J---L(XH(DLK98[=]\*")0(FYY48X/)
MY'J:;=Y-DI621Q.M^)=7T>SNHENO-N=,NUGN6:)<RV99"> ,#AR,@?\ +,U>
MO-=U"QG-X;D26>HI)'81%%PLHVB+! R=_P S<D]JZJ6PLYWF::T@D:>/R92\
M8)D3GY6R.5Y/!XY-.DL[65(4DMH76%@\2L@(C8="OH1VQ2]?Z_K\Q_U_7];6
M.;\/ZO?WEY'8W=TK2Z>DD=^^Q5\R3?MC/ XRJLV!CJ*K3:GJ2G6KU=6)%A?K
M#'9B./:RD1_(QV[LG<<$$=1UKJGTZQD,I>RMV,SK)+F)3O9<;6;CDC P3TP*
MI6GAZQM]0N;Z6WMY[J6X,\<SP+OBRH& W)['TZTT]=?ZU7_!$]M/ZT9A6]_J
MTD$3R:I*/MNJ36:L(HP+:-'EV[?EY8[%7+9'(XSUBU+7]5TN*Z$-W]LEM+OR
M%5XAF=6B#DG8O6/)8[0 0,8R178/I]E):O:R6D#6TA+/"T8*,2<DD8P<DY^M
M-@TVQM1&+>RMX1$K+'Y<2KL#') P. 2!GZ4BF];G-2:O?V]_%I*ZC]HFOOL[
MV=R8T^:/'[X@ 8. A;IUD'M58^)-3%K/&LZ_:-,A=+UW08\PR;$<@8P-H:0@
M8X([5T<6BQQZQ#>CR%AM8&AM8(H=@B#%2Q)S@_=&, 8YZU?6TMD>=UMXE:X.
M9B$ ,AQCYO7CCGM3_K^OZW%_P#CO$;WT.E:[IK:K/<H-*>Y\XI$)$/(VG:H&
MUL<<9X;GTFN;[6_M]S9V#7DTEE#$8\"V"3%AG,N[# '&/D Z'J>G36VE:=96
M\EO:V%K!#+_K(XH557XQR ,'CBHFT+1W6!7TJQ9;<8A!MT(BYS\O''//%%P?
M]?@5]<O9X5L;:WG^SM=7(@DN %8P@JS< @C)*A1D$98<&J<AOVU:32_[:N8$
MM[07'VAHX2\Q9G!SE-NU0HZ 'YAD^NW)IUC,EPDMG;NER<SJT2D2G 'S<?-P
M .?2H&T'1WMXK=]*L6AB):.,VZ%4)Y) Q@9I#.1.N:W=Z3?ZG'?_ &8VNG07
M20)"A1W96)W;@6VG:. 0>>M=%IES=0:U?Z?=WSW4<5O!.LLJHI4N7!7Y0!CY
M!C//)Y-:KV5K(LJO;0L)E"2AHP=ZCH&]1R>#236%G<>9YUI!+YJJLF^,-O"D
ME0<]0"21Z9IW1/0L4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,F,JP2&!$>8*
M3&DCE%9L< L 2!GO@_0UC?:O%7_0&T;_ ,&TO_R-6Y10!E6=QK[W2+>Z9ID-
MN<[Y(=0DE<<<84PJ#SCN/Z47EQKZ73K9:9IDUN,;))]0DB<\<Y40L!SGN?Z5
MJT4 8?VKQ5_T!M&_\&TO_P C5>N9=52PA>ULK.6\.WS8I;MHXUXYVN(V+8.
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M+4)-0C@4Z=;6UQ-NP4N+AH5"X/.Y4<DYQQC\?6U10!A_:O%7_0&T;_P;2_\
MR-6EI\FH20,=1MK:WFW8"6]PTRE<#G<R(0<YXQ^/I:HH P_M7BK_ * VC?\
M@VE_^1JGL[C7WND6]TS3(;<YWR0ZA)*XXXPIA4'G'<?TK5HH SM0FUJ.=1IV
MGV%Q#MR7N+YX6#9/&U8G!&,<Y_#UJ?:O%7_0&T;_ ,&TO_R-6Y10!!9O=/:H
MU[###<'.^.&4RH.>,,54GC'8?UJ>BB@ HHHH ***X36_BQH.D:NVE6\%]JEY
M&2LJ6$0<1D<$$DC)SZ9H [NBO.?^%NV__0I^)?\ P#'_ ,51_P +=M_^A3\2
M_P#@&/\ XJ@#T:BO.?\ A;MO_P!"GXE_\ Q_\51_PMVW_P"A3\2_^ 8_^*H
M]&HKSG_A;MO_ -"GXE_\ Q_\51_PMVW_ .A3\2_^ 8_^*H ]&HKSG_A;MO\
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M2_\ @&/_ (J@#T:BO.?^%NV__0I^)?\ P#'_ ,51_P +=M_^A3\2_P#@&/\
MXJ@#T:BO.?\ A;MO_P!"GXE_\ Q_\51_PMVW_P"A3\2_^ 8_^*H ]&HKSG_A
M;MO_ -"GXE_\ Q_\51_PMVW_ .A3\2_^ 8_^*H ]&HKSG_A;MO\ ]"GXE_\
M ,?_ !5'_"W;?_H4_$O_ (!C_P"*H ]&HKSG_A;MO_T*?B7_ , Q_P#%4?\
M"W;?_H4_$O\ X!C_ .*H ]&HKSG_ (6[;_\ 0I^)?_ ,?_%4?\+=M_\ H4_$
MO_@&/_BJ /1J*\Y_X6[;_P#0I^)?_ ,?_%4?\+=M_P#H4_$O_@&/_BJ /1J*
M\Y_X6[;_ /0I^)?_  #'_P 51_PMVW_Z%/Q+_P" 8_\ BJ /1J*\Y_X6[;_]
M"GXE_P# ,?\ Q5'_  MVW_Z%/Q+_ . 8_P#BJ /1J*\Y_P"%NV__ $*?B7_P
M#'_Q5'_"W;?_ *%/Q+_X!C_XJ@#T:BO.?^%NV_\ T*?B7_P#'_Q5'_"W;?\
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M /0I^)?_  #'_P 51_PMVW_Z%/Q+_P" 8_\ BJ /1J*\Y_X6[;_]"GXE_P#
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M^M=0CB7[5?/*\\I'S/MD90"?3"_J:[+7_P#D7-4_Z])?_0#7,?"#_DENC?\
M;?\ ]'R4 =Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV9R\K@;05P,%3USGO2OI=;V7SN"6OS:^XZK5?&]A96.F36,,VI7.J@&QMK?
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ME\_\[%-:M'K5%-CSY:Y8,<#+#O[UROCK2_#DND3ZKXC1Y(+6%@B^>Z#<>FT
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M^$'_ "2W1O\ MO\ ^CY*Z?7_ /D7-4_Z])?_ $ US'P@_P"26Z-_VW_]'R4
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M?9?,1U8H/,QNP-V>_'/YU/X\\4W_ (=LK2+1[>"YU6[D810S E=B*6<X!!X
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M&NX4444AA1110 4444 %%%% !1110 4444 %%%% !7#_ !?_ .26ZS_VP_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ # '&*G2PB359=1#/YTL*0,N1MVJ6(QQU^<_I2[#OH_ZZG*6'BO[-811O+
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MB!GIC&$N_#5M>?: ;FZC2YLA93(A3#H P!Y4D,-[=,#GD&A?U^)2:3_KNO\
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M\%@Q)"J!G([8'M5:#P];VKZ<\%S<HUA&T2$%3YB,5)5LKZJ.1@\=::M=?/\
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M*Q30J5"G;G:P.-P89[''M4ECI*V=U)=2WES>7+H(_-N-F50<X 15'7DG&3^
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MF'6M35=0_LVS$RQ&:5Y$ABC#;=SLP4 GL.>3Z>M03Z+]JN+>2XU&\EB@9)!
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ME/KY?U_P"7>VG]?UJ5[_ ,5R:;*+:Y@T^*\2#[1+%)J&P;"S!0A*?.QVGC
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MJWEU&TMP+I-A3]Q*%VEDRIZC@ALCD\5<T[38].68B66>:>3S)IIB-SM@ 9P
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ME<?A21?1_P!=48%TTU[X<M[F:[O!<Q:DEDTL-U)$)46Z$9)",!DKU..]=G!
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M?D=>]4Y/#L!N'NH+NZMKIIGE$T10L-X4,N&4@J=B]0>1UK4@C:*".-YGF95
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MMVSO<7C8C6*<(3G:2<[LA>@X'3D:4OA^VN+[3+VXGN);C3U*J[,!YN1C,@
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M+'(A:0K\Y=][,0 !DMZ8'/2A?Y_K_F)ZK[OPM_D9=]XRCL]*M=2,=DD,MO\
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M(JH4'.(^IW] #T]^->/P_#'>6DOVJY:"S.;:U.P1P_)LX(4,>">K'K],9?\
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M=Q7#_%__ ));K/\ VP_]'QT =/H'_(N:7_UZ1?\ H K1K.T#_D7-+_Z](O\
MT 5HT %%%% &=K__ "+FJ?\ 7I+_ .@&N8^$'_)+=&_[;_\ H^2NGU__ )%S
M5/\ KTE_] -<Q\(/^26Z-_VW_P#1\E '<4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7#_%_P#Y);K/_;#_
M -'QUW%</\7_ /DENL_]L/\ T?'0!T^@?\BYI?\ UZ1?^@"M&L[0/^1<TO\
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M./K2?6W];_\  !=+_P!;?\'[B[?^-]+L9"%CNKI(X$N9Y+>,,L$3 E6;)!Y
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M-GG'! QZXJW'XQT^5[Z18;K[!8^8)]0* 0*R?>4'.XD>RXSWK/7P)C38;/\
MM+_5ZS_:N_R.OSEO+QN]\;OTJ1/!1CMM2TL:EG0[\RN]H8!YB-)R=LF[IDY
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M!;D<YQVHDKK3S_+_ #*B[-7_ *U7_!(_"'BJ&_M=*TNXCO4OI-.CN%FN4XN
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MV2X@CN=T"+MCB?[K-N8'\ ":K+X(AAN;U[:[,<$^DII<<1CSY:KN ;.>>O3
MZ=:K2^ 3/;Z);2ZC%Y6EQPJLB686X)CQ]V7=E V.1@_6GI?^O/\ X M;?UY?
M\$[2BJMA!>6\,BWMX+MVE9D<0B/:A/RK@$YP.,]ZM4AA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P_Q?\
M^26ZS_VP_P#1\==Q7#_%_P#Y);K/_;#_ -'QT =/H'_(N:7_ ->D7_H K1K.
MT#_D7-+_ .O2+_T 5HT %%%% &=K_P#R+FJ?]>DO_H!KF/A!_P DMT;_ +;_
M /H^2NGU_P#Y%S5/^O27_P! -<Q\(/\ DENC?]M__1\E '<4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI%_Z *T:SM _Y%S2_P#KTB_] %:- !1110!G:_\ \BYJG_7I+_Z :YCX0?\
M)+=&_P"V_P#Z/DKI]?\ ^1<U3_KTE_\ 0#7,?"#_ ));HW_;?_T?)0!W%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %</\7_\ DENL_P#;#_T?'7<5P_Q?_P"26ZS_ -L/_1\=
M '3Z!_R+FE_]>D7_ * *T:SM _Y%S2_^O2+_ - %:- !1110!G:__P BYJG_
M %Z2_P#H!KF/A!_R2W1O^V__ */DKI]?_P"1<U3_ *])?_0#7,?"#_DENC?]
MM_\ T?)0!W%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5P_Q?\ ^26ZS_VP_P#1\==Q7#_%_P#Y);K/_;#_
M -'QT =/H'_(N:7_ ->D7_H K1K.T#_D7-+_ .O2+_T 5HT %%%% &=K_P#R
M+FJ?]>DO_H!KF/A!_P DMT;_ +;_ /H^2NGU_P#Y%S5/^O27_P! -<Q\(/\
MDENC?]M__1\E '<4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7#_%__ ));K/\ VP_]'QUW%</\7_\ DENL
M_P#;#_T?'0!T^@?\BYI?_7I%_P"@"M&L[0/^1<TO_KTB_P#0!6C0 4444 9V
MO_\ (N:I_P!>DO\ Z :YCX0?\DMT;_MO_P"CY*Z?7_\ D7-4_P"O27_T US'
MP@_Y);HW_;?_ -'R4 =Q1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %</\7_ /DENL_]L/\ T?'7<5P_Q?\
M^26ZS_VP_P#1\= '3Z!_R+FE_P#7I%_Z *T:SM _Y%S2_P#KTB_] %:- !11
M10!G:_\ \BYJG_7I+_Z :YCX0?\ )+=&_P"V_P#Z/DKI]?\ ^1<U3_KTE_\
M0#7,?"#_ ));HW_;?_T?)0!W%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5P_Q?_P"26ZS_ -L/_1\==Q7#
M_%__ ));K/\ VP_]'QT =/H'_(N:7_UZ1?\ H K1K.T#_D7-+_Z](O\ T 5H
MT %%%% &=K__ "+FJ?\ 7I+_ .@&N8^$'_)+=&_[;_\ H^2NGU__ )%S5/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5P_Q?_Y);K/_ &P_]'QUW%</\7_^26ZS_P!L/_1\= '3
MZ!_R+FE_]>D7_H K1K.T#_D7-+_Z](O_ $ 5HT %%%% &=K_ /R+FJ?]>DO_
M * :YCX0?\DMT;_MO_Z/DKI]?_Y%S5/^O27_ - -<Q\(/^26Z-_VW_\ 1\E
M'<4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#VKK:*'K=OJ"TM;H<MI_@W[#<>&I?M^_^Q;22VQY./.W*%W?>^7&WIS6A/H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\
M\"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__
M / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'
M?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO
M!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110
M?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_Z
MU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_
M^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\
M\"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__
M / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'
M?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO
M!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110
M?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_Z
MU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_
M^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\
M\"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__
M / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'
M?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO
M!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110
M?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_Z
MU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_
M^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\
M\"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__
M / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'
M?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO
M!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110
M?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_Z
MU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_
M^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\
M\"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU'_"CO!W]V__
M / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO!W]V_P#_  (_^M110 ?\*.\'
M?W;_ /\  C_ZU'_"CO!W]V__ / C_P"M110 ?\*.\'?W;_\ \"/_ *U'_"CO
M!W]V_P#_  (_^M110 ?\*.\'?W;_ /\  C_ZU:WA_P"%WA7PYJ"W]I9/+=)S
:')<2%_+/J!TS[XS110!V5%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
